10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended May 04, 2019

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 0-21196

Destination Maternity Corporation

(Exact name of registrant as specified in its charter)

Delaware	13-3045573
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)
232 Strawbridge Drive Moorestown, New Jersey	08057
(Address of principal executive offices)	(Zip code)

(856) 291-9700

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	DEST	NASDAQ

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act    ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes  ☐    No   ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Common Stock, $.01 par value — 14,339,786 shares outstanding as of June 3, 2019

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

INDEX

PART I. FINANCIAL INFORMATION
Item 1.	Financial Statements	3
	Consolidated Balance Sheets	3
	Consolidated Statements of Operations	4
	Consolidated Statements of Comprehensive Income	5
	Consolidated Statements of Stockholders’ Equity	6
	Consolidated Statements of Cash Flows	7
	Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	18
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	25
Item 4.	Controls and Procedures	26
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	27
Item 1A.	Risk Factors	27
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	27
Item 6.	Exhibits	28
Signatures		29

2

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share amounts)

           (unaudited)

	May 4, 2019			February 2, 2019
ASSETS
Current assets:
Cash and cash equivalents	$	1,193		$	1,154
Trade receivables, net		8,807			7,945
Inventories		72,133			70,872
Prepaid expenses and other current assets		9,855			9,407
Total current assets		91,988			89,378
Property and equipment, net of accumulated depreciation and amortization of    $108,556 and $106,479		50,510			51,483
Operating lease assets		128,065			—
Deferred income taxes		3,314			2,671
Other non-current assets		1,918			2,642
Total assets	$	275,795		$	146,174
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Line of credit borrowings	$	26,200		$	20,400
Current portion of long-term debt		4,257			4,372
Accounts payable		21,355			21,854
Operating lease liabilities		32,327			—
Accrued expenses and other current liabilities		24,608			31,056
Total current liabilities		108,747			77,682
Long-term debt		22,294			21,784
Operating lease and other non-current liabilities		119,938			19,557
Total liabilities		250,979			119,023
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock, 1,656,381 shares authorized, none outstanding		—			—
Common stock, $.01 par value; 20,000,000 shares authorized, 14,375,658 and    14,416,500 shares issued and outstanding		144			144
Additional paid-in capital		107,785			107,675
Accumulated deficit		(83,039	)		(80,594	)
Accumulated other comprehensive loss		(74	)		(74	)
Total stockholders’ equity		24,816			27,151
Total liabilities and stockholders’ equity	$	275,795		$	146,174

The accompanying notes are an integral part of these consolidated financial statements.

3

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

	Three Months Ended
	May 4, 2019		May 5, 2018
Net sales	$	94,213	$	103,227
Cost of goods sold		42,616		47,824
Gross profit		51,597		55,403
Selling, general and administrative expenses		48,490		51,857
Store closing, asset impairment and asset disposal expenses		869		969
Other charges		662		1,150
Operating income		1,576		1,427
Interest expense, net		1,415		1,157
Income before income taxes		161		270
Income tax provision		31		56
Net income	$	130	$	214
Net income per share— Basic	$	0.01	$	0.02
Average shares outstanding— Basic		13,825		13,839
Net income per share— Diluted	$	0.01	$	0.02
Average shares outstanding— Diluted		13,901		13,963

The accompanying notes are an integral part of these consolidated financial statements.

4

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in thousands)

(unaudited)

	Three Months Ended
	May 4, 2019		May 5, 2018
Net income	$	130	$	214
Foreign currency translation adjustments		—		—
Comprehensive income	$	130	$	214

The accompanying notes are an integral part of these consolidated financial statements.

5

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)

(unaudited)

	Common Stock												Accumulated
	Number of Shares			Amount			Additional Paid-in Capital			Accumulated Deficit			Other Comprehensive Loss			Total
Balance as of February 2, 2019		14,417		$	144		$	107,675		$	(80,594	)	$	(74	)	$	27,151
Adoption of ASC 842 - Leases		—			—			—			(2,576	)		—			(2,576	)
Net income		—			—			—			130			—			130
Dividends forfeited		—			—			—			1			—			1
Stock-based compensation		75			1			143			—			—			144
Repurchase and retirement of common stock		(116	)		(1	)		(33	)		—			—			(34	)
Balance as of May 4, 2019		14,376		$	144		$	107,785		$	(83,039	)	$	(74	)	$	24,816
Balance as of February 3, 2018		14,684		$	147		$	106,865		$	(66,274	)	$	(70	)	$	40,668
Net income		—			—			—			214			—			214
Dividends forfeited		—			—			—			1			—			1
Stock-based compensation		383			4			324			—			—			328
Repurchase and retirement of common stock		(62	)		(1	)		(18	)		—			—			(19	)
Balance as of May 5, 2018		15,005		$	150		$	107,171		$	(66,059	)	$	(70	)	$	41,192

The accompanying notes are an integral part of these consolidated financial statements.

6

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

	Three Months Ended
	May 4, 2019			May 5, 2018
Operating Activities
Net income	$	130		$	214
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization		3,553			4,050
Stock-based compensation expense		144			328
Loss on impairment of long-lived assets		562			887
Loss on disposal of assets		188			13
Grow NJ award benefit		(643	)		(707	)
Amortization of deferred financing costs		177			165
Changes in assets and liabilities:
Decrease (increase) in:
Trade receivables		(862	)		(2,197	)
Inventories		(1,261	)		4,837
Prepaid expenses and other current assets		(448	)		(252	)
Operating leases and other non-current assets		6,317			(14	)
Decrease in:
Accounts payable, accrued expenses, operating leases and other current liabilities		(4,931	)		(9,031	)
Operating leases and other non-current liabilities		(7,522	)		(752	)
Net cash used in operating activities		(4,596	)		(2,459	)
Investing Activities
Capital expenditures		(2,478	)		(1,141	)
Net cash used in investing activities		(2,478	)		(1,141	)
Financing Activities
Decrease in cash overdraft		1,106			(1,980	)
Increase in line of credit borrowings		5,800			7,200
Proceeds from long-term debt		1,802			—
Repayment of long-term debt		(1,562	)		(1,151	)
Deferred financing costs paid		—			(80	)
Withholding taxes on stock-based compensation paid in connection    with repurchase of common stock		(33	)		(19	)
Net cash provided by financing activities		7,113			3,970
Effect of exchange rate changes on cash and cash equivalents		—			—
Net Increase in Cash and Cash Equivalents		39			370
Cash and Cash Equivalents, Beginning of Period		1,154			1,635
Cash and Cash Equivalents, End of Period	$	1,193		$	2,005
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	$	1,218		$	968
Cash received for income taxes	$	(198	)	$	—

The accompanying notes are an integral part of these consolidated financial statements.

7

DESTINATION MATERNITY CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited consolidated financial statements for the three months ended May 4, 2019 and May 5, 2018 have been prepared in accordance with the requirements for Form 10-Q and Article 10 of Regulation S-X, and accordingly, certain information and footnote disclosures have been condensed or omitted. See the Company’s Annual Report on Form 10-K as of and for the year ended February 2, 2019 for Destination Maternity Corporation and subsidiaries (the “Company” or “Destination Maternity”) as filed with the Securities and Exchange Commission (“SEC”) for additional disclosures, including a summary of the Company’s accounting policies.

In the opinion of management, the consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. Since the Company’s operations are seasonal, the interim operating results of the Company may not be indicative of operating results for the full year. Certain prior year amounts have been reclassified to conform to current year presentation.

The Company operates on a 52/53-week fiscal year ending on the Saturday nearest January 31 of each year. References to the Company’s fiscal 2019 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 3, 2019 and will end February 1, 2020. References to the Company’s fiscal 2018 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 4, 2018 and ended February 2, 2019.

2. EARNINGS PER SHARE (“EPS”)  

Basic net income per share (“Basic EPS”) is computed by dividing net income by the weighted average number of common shares outstanding, excluding restricted stock awards for which the restrictions have not lapsed. Diluted net income per share (“Diluted EPS”) is computed by dividing net income by the weighted average number of common shares outstanding, after giving effect to the potential dilution, if applicable, from the assumed lapse of restrictions on restricted stock and restricted stock unit (“RSU”) awards, and from shares of common stock resulting from the assumed exercise of outstanding stock options. Common shares issuable in connection with the award of performance-based restricted stock units (“PRSUs”) are excluded from the calculation of EPS until the PRSUs’ performance conditions are achieved and the shares in respect of the PRSUs become issuable (see Note 14).

The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts):

	Three Months Ended
	May 4, 2019						May 5, 2018
	Net Income		Shares		EPS		Net Income		Shares		EPS
Basic EPS	$	130		13,825	$	0.01	$	214		13,839	$	0.02
Incremental shares from the assumed exercise of outstanding stock options		—		—		—		—		—		—
Incremental shares from the assumed lapse of restrictions on restricted stock and RSU awards		—		76		—		—		124		—
Diluted EPS	$	130		13,901	$	0.01	$	214		13,963	$	0.02

  Stock options and unvested restricted stock totaling 959,000 shares of the Company’s common stock were outstanding as of May 4, 2019, of which 610,000 shares were excluded from the calculation of Diluted EPS as the effect would have been antidilutive.   

8

3. TRADE RECEIVABLES

Trade receivables are recorded based on revenue recognized for sales of the Company’s merchandise and for other revenue earned by the Company through its marketing partnership programs and international franchise agreements, and are non-interest bearing. The Company evaluates the collectability of trade receivables based on a combination of factors, including aging of trade receivables, write-off experience, analysis of historical trends and expectations of future performance. An allowance for doubtful accounts is recorded for the amount of trade receivables that are considered unlikely to be collected. When the Company’s collection efforts are unsuccessful, uncollectible trade receivables are charged against the allowance for doubtful accounts. As of May 4, 2019 and February 2, 2019, the Company’s trade receivables were net of allowance for doubtful accounts of $166,000 and $166,000, respectively.

4. INVENTORIES

Inventories were comprised of the following (in thousands):

	May 4, 2019		February 2, 2019
Finished goods	$	71,992	$	70,660
Work-in-progress		46		148
Raw materials		95		64
Total	$	72,133	$	70,872

5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities were comprised of the following (in thousands):

	May 4, 2019		February 2, 2019
Employee compensation and benefits	$	4,376	$	6,741
Insurance, primarily self-insurance reserves		3,125		3,049
Sales and use taxes		3,086		2,737
Accrued expenses		3,073		4,561
Gift certificates and store credits		2,915		3,464
Product return reserve		2,530		2,078
Deferred revenue		1,713		2,435
Audit and legal		1,463		1,341
Deferred rent		—		3,101
Other		2,327		1,549
Total	$	24,608	$	31,056

6. LINE OF CREDIT

After completion of a debt refinancing on February 1, 2018, the Company has in place a $50,000,000 senior secured revolving credit facility (the “Credit Facility”), which was entered into in conjunction with the issuance of the Company’s $25,000,000 Term Loan (as defined below) (see Note 7). Proceeds from advances under the Credit Facility, subject to certain restrictions, may be used to provide financing for working capital, letters of credit, capital expenditures, and other general corporate purposes.

9

The Credit Facility, which matures on January 31, 2023, contains various affirmative and negative covenants and representations and warranties, including the requirement that the Company maintain Excess Availability (as defined in the related Credit Agreement) of more than the greater of 10% of the Combined Loan Caps (as defined in the related Credit Agreement) and $7,000,000. In the event that the outstanding balance of the Term Loan exceeds the Term Loan Borrowing Base (as defined in the related Term Loan Agreement), then a reserve will be imposed against availability under the Credit Facility. The Credit Facility is secured by a security interest in the Company’s trade receivables, inventory, letter of credit rights, cash, intangibles and certain other assets. The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%. The Company also pays an unused line fee under the Credit Facility of 0.25% per annum.

Any amounts outstanding under the Credit Facility may be accelerated and become due and payable immediately and all loan and letter of credit commitments thereunder may be terminated upon an event of default and expiration of any applicable cure period. Events of default include: 1) nonpayment of obligations due under the subject loan agreement and related loan documents, 2) cross-defaults to other indebtedness and documents, 3) failure to perform any covenant or agreement contained in the subject loan agreement, 4) material misrepresentations, 5) failure to pay, or certain other defaults under, other material indebtedness of the Company, 6) certain bankruptcy or insolvency events, 7) a change of control, 8) indictments of the Company or senior management in a material forfeiture action, 9) default under certain material contracts to the extent such termination or default has or could reasonably be expected to have a material adverse effect, and 10) customary ERISA defaults, among others.

In connection with the original execution and subsequent amendments of the Credit Facility, the Company has incurred deferred financing costs of $1,281,000.  These deferred financing costs are being amortized over the term of the Credit Facility agreement and are included in “interest expense, net” in the consolidated statements of operations.

As of May 4, 2019, the Company had $26,200,000 in outstanding borrowings under the Credit Facility, $6,297,000 in letters of credit and $10,128,000 of availability based on the Company’s Borrowing Base formula and availability reserve requirements. As of May 5, 2018, the Company had $15,200,000 in outstanding borrowings under the Credit Facility, $7,327,000 in letters of credit and $20,223,000 of availability. For the three months ended May 4, 2019 and May 5, 2018 borrowings had a weighted interest rate of 4.53% and 3.60% per annum, respectively.During the three months ended May 4, 2019 and May 5, 2018 the Company’s average levels of direct borrowings were $27,509,000 and $19,436,000, respectively, and the Company’s maximum borrowings were $32,300,000 and $27,400,000, respectively.

7. LONG-TERM DEBT

On February 1, 2018 (the “Closing Date”), the Company has entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25,000,000 and matures on January 31, 2023 (the “Term Loan”).  On the Closing Date, the Company borrowed $22,500,000.   The Term Loan provided for an additional loan of $2,500,000, which could be borrowed at the Company’s discretion within a period of 45 days after delivery to the lender of the Company’s first quarter fiscal 2018 financial statements and satisfaction of certain other requirements. The Company met these requirements and borrowed the additional $2,500,000 on July 16, 2018.   

The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%. The Company is required to make minimum repayments of the principal amount of the Term Loan in quarterly installments of $312,500 which commenced on July 31, 2018, with the remaining outstanding balance payable on the maturity date. There is a minimum excess availability requirement of the greater of 10% of the Combined Loan Cap, as defined in the Term Loan Agreement, or $7,000,000. Additionally, the Term Loan can be prepaid at the Company’s option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of  a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount, if paid between the second and third anniversary of the Closing Date.

10

The Term Loan is secured by a security interest in substantially all of the assets of the Company, including accounts receivable, inventory, equipment, letter of credit rights, cash, intellectual property and other intangibles, and certain other assets. The security interest granted to the Term Lenders is, in certain respects, subordinate to the security interest granted to the Credit Facility Lender. The Term Loan Agreement prohibits the payment of dividends or share repurchases by the Company for three years and imposes certain restrictions on the Company’s ability to, among other things, incur additional indebtedness and enter into other various types of transactions.

        There were $2,455,000 of deferred financing costs incurred in connection with the Term Loan. These deferred financing costs are reflected as a direct deduction from the Term Loan liability in the consolidated balance sheets and are being amortized over the term of the Term Loan Agreement. The amortization is included in “interest expense, net” in the consolidated statements of operations.

As of May 4, 2019 and May 5, 2018, there was $23,750,000 and $22,500,000, respectively, of principal outstanding under the Term Loan.

On February 22, 2019, the Company entered into a 24-month, $1,802,000 software development financing arrangement. The note has monthly payments of $81,648 with an interest rate of 8.16%. As of May 4, 2019, there was $1,593,000 of principal outstanding.

As of May 4, 2019 and May 5, 2018, there was $2,149,000 and $5,284,000, respectively, outstanding under a five-year equipment financing arrangement with the Company’s Credit Facility bank. The equipment note bears annual interest at 3.38%, with payments of $272,000 (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at the Company’s distribution facility in Florence, New Jersey. Any amounts outstanding under the equipment note may be accelerated and become due and payable immediately upon an event of default and expiration of any applicable cure period. The specified events of default are substantially the same as those in the Credit Facility agreement (see Note 6).

On June 6, 2017, the Company received $3,401,000 in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software. Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36. At the end of the leaseback term, the Company has the option to extend the lease for an additional year or to repurchase the financed property for a price to be agreed upon. As of May 4, 2019, and May 5, 2018, there was $1,114,000 and $2,287,000 of principal outstanding under this financing arrangement.

8. LEASES

The Company has entered into operating leases for all of its retail locations, distribution center and corporate office. Many of these leases include one or more renewal options which can extend the lease for up to an additional 15 years. In the event we are reasonably certain that an option to extend a lease will be exercised, we use the expected expiration date to determine the operating lease right-of-use asset and lease liability. We also have short-term leases that can be terminated by the Company or by the landlord with notification periods as short as 30 days, which are excluded from the operating lease liability. Some of our leases provide for rental payments based solely on a percent of retail sales which are treated as variable lease expenses and not included as part of the operating lease liability.  Most leases include payments for lease components such as minimum rent, non-lease components such as common area maintenance and not-lease components such as real estate taxes and insurance.  Finance leases were not material as of May 4, 2019 and the three-month period then ended.  

For the three months ended May 4, 2019, the components of lease expense were as follows (in thousands):

Fixed operating lease expense (1)	$	8,743
Variable operating lease expense		3,893
Total operating lease expense	$	12,636
(1) Includes short-term leases.

For the three months ended May 5, 2018, rent expense, including related occupancy costs such as insurance and maintenance paid to landlords, for non-cancellable operating leases amounted to $12.8 million.

The following table presents the operating lease balances within the Consolidated Balance Sheet, weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of May 4, 2019 ($ in thousands):

11

Lease Assets and Liabilities	Classification
Assets:
Operating lease ROU assets	Operating lease assets	$	128,065
Liabilities:
Current:
Operating lease liabilities	Operating lease liabilities	$	32,327
Long-term:
Operating lease liabilities	Operating lease and other non-current liabilities		119,636
Total undiscounted operating lease liabilities		$	151,963
Weighted average remaining lease term		6.4 years
Weighted average discount rate			7.40	%

The following table presents the maturity of the Company’s operating lease liabilities as of May 4, 2019 (in thousands):

Remainder of Fiscal 2019	$	32,864
2020		34,750
2021		28,555
2022		24,128
2023		20,969
Thereafter		53,693
Total operating lease payments		194,959
Less: Imputed interest		42,996
Total operating lease liabilities	$	151,963

The following table presents future minimum lease payments as previously disclosed in our 2018 Annual Report on Form 10-K  determined using the previous lease accounting standard.

2019	$	36,417
2020		29,682
2021		21,142
2022		21,698
2023		15,995
Thereafter		48,462
Total operating lease liabilities	$	173,396

Supplemental cash flow information related to the Company’s operating leases for the three months ended May 4, 2019 (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities	$	11,994
ROU assets obtained in exchange for operating lease liability		1,829

9. FAIR VALUE MEASUREMENTS

The accounting standard for fair value measurements defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a framework for measuring fair value focused on exit price and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements as follows:

• Level 1 – Quoted market prices in active markets for identical assets or liabilities

• Level 2 – Observable market-based inputs or inputs that are corroborated by observable market data

• Level 3 – Unobservable inputs that are not corroborated by market data

12

At both May 4, 2019and February 2, 2019, the Company had cash equivalents of $4,000. The Company’s cash equivalents consist of investments in money market funds for which the carrying value approximates fair value (based on Level 1 inputs) due to the short-term nature of those instruments. The carrying values of trade receivables and accounts payable approximate fair value due to the short-term nature of those instruments.

The Company’s Credit Facility has variable interest rates that are tied to market indices. As of May 4, 2019 and February 2, 2019, the Company had $26,200,000 and $20,400,000 respectively, of direct borrowings outstanding under the Credit Facility. The carrying value of the Company’s Credit Facility borrowings approximates fair value as the variable interest rates approximate current market rates, which the Company considers to be Level 2 inputs.

The Company’s Term Loan, which represents a significant majority of the Company’s long-term debt, bears interest at variable rates, which adjust based on market conditions with a minimum annual rate of 9.00%. The carrying value of the Company’s Term Loan approximates fair value as the variable interest rates approximate current market rates for similar instruments available to companies with comparable credit quality, which the Company considers to be Level 2 inputs. The fair value of the Company’s fixed-rate equipment notes were determined using a discounted cash flow analysis based on interest rates currently available to the Company, which the Company considers to be Level 2 inputs. The difference between the carrying value and fair value of long-term debt held by the Company with a fixed rate of interest is not material.

10. NET SALES

The following disaggregates the Company’s net sales by major source (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Retail stores	$	56,464	$	62,987
Leased departments		9,348		9,989
Total retail locations		65,812		72,976
E-commerce		22,672		25,482
Marketing partnerships		4,580		3,935
Wholesale and franchise		1,150		834
Total net sales	$	94,213	$	103,227

11. OTHER CHARGES

Over the last several years the Company has engaged in a series of management and organizational changes and, in connection therewith, retained consulting firms to review its costs and business strategy associated with such management and organizational changes.  The Company’s Board of Directors authorized changes to the Company’s chief executive function, including, most recently, the May 23, 2018 appointment of Marla Ryan as Chief Executive Officer, who replaced Melissa Payner-Gregor who had served as interim Chief Executive Officer since January 2, 2018. Ronald Masciantonio, the Company’s Chief Administrative Officer, resigned from his position on June 4, 2018.  David Stern, the Company’s former Chief Financial Officer, departed the Company effective at the close of business on August 10, 2018. On January 19, 2019, Dave J. Helkey was appointed Chief Operating Officer and Chief Financial Officer. The Company also paid one-time retention bonuses with service conditions to certain key management personnel which are being recorded over the service period, while reducing its overall headcount to create a more efficient and effective operating structure. During the three months ended May 4, 2019 and May 5, 2018, the Company incurred $662,000 and $264,000, respectively, of charges related to these management and organizational changes.

In the first quarter of fiscal 2018, the Company received notification from a stockholder group of their intent to nominate a slate of alternative nominees for election to the Company’s Board of Directors at the Annual Meeting of Stockholders that was held on May 23, 2018 (the “Proxy Solicitation”).  At the 2018 Annual Meeting of Stockholders the Company’s stockholders replaced the incumbent board in its entirety and elected Holly N. Alden, Christopher B. Morgan, Marla A Ryan and Anne-Charlotte Windal as the Company’s new Board of Directors. During the three months ended May 5, 2018, the Company incurred $886,000 of charges related to the Proxy Solicitation. 

A summary of charges incurred in connection with management and organizational changes and the proxy solicitation is as follows (in thousands):

13

	Three Months Ended
	May 4, 2019		May 5, 2018
Management and organizational changes	$	662	$	264
Proxy solicitation		—		886
Total other charges	$	662	$	1,150

12. GOVERNMENT INCENTIVES

In fiscal 2015, the Company completed the relocation of its corporate headquarters and distribution operations from Philadelphia, Pennsylvania to southern New Jersey. To partially offset the costs of these relocations, the Board of the New Jersey Economic Development Authority (“NJEDA”) approved the Company for an incentive package of up to $40,000,000 in benefits under the Grow New Jersey Assistance Program (“Grow NJ”) in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The award provides annually over a ten-year period up to $7,000 per eligible new full-time job, as defined under Grow NJ, with a requirement that at least 100 eligible jobs be created and subject to an annual award limit of $4,000,000.

The Grow NJ award requires an annual compliance report that includes certification of average annual employment figures after the end of each fiscal year. After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period. The Company believes the likelihood of any recapture and repayment is remote.

The annual benefit from the Grow NJ award available to the Company is expected to significantly exceed the Company’s annual income tax liability to the State of New Jersey. In order to maximize the realizable value of the incentive package, the Company entered into an agreement with a third party to sell up to 100% of the annual income tax credits awarded to the Company. The Company recognizes its Grow NJ award on an annual basis for each fiscal year based on the realizable value of the award earned and expected to be received, primarily from the sale of the income tax credits, net of any associated costs. The Grow NJ award is reflected in the Company’s consolidated financial statements as a reduction to the costs incurred by the Company in connection with the relocations. The expected realizable amount of the Grow NJ award is included in the consolidated balance sheet in deferred income taxes. As of May 4, 2019, the Company had recorded a deferred tax asset of $3,314,000 related to the NJ Grow award. Of this amount, $2,671,000 relates to the annual award earned in fiscal 2018, the cash proceeds of which are expected to be received during fiscal 2019. In December 2018, the Company received $2,829,000 cash proceeds, net of costs, from the receipt and subsequent sale of the  tax credit certificate earned for fiscal 2017. During the three months ended May 4, 2019, the Company recognized a cost reduction related to the Grow NJ award in the amount of $617,000,as compared to the three months ended May 5, 2018 in which the Company recognized $710,000.  

13. INCOME TAXES

 Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, requires that a valuation allowance be recorded to reduce deferred tax assets when it is more likely than not that the tax benefit of the deferred tax assets will not be realized. In situations where a three-year cumulative loss condition exists, accounting standards limit the ability to consider projections of future results as positive evidence to assess the realizability of deferred tax assets.  In fiscal 2016 the Company’s financial results reflected a three-year cumulative loss and consequently, in fiscal 2016 the Company recorded a non-cash charge as a valuation allowance against substantially all of its deferred tax assets.  Three-year cumulative losses have continued since fiscal 2016, and the Company continues to record a valuation allowance against its deferred tax assets.

14. EQUITY AWARD PLANS

In January 2006, the stockholders of the Company approved the adoption of the Amended and Restated 2005 Equity Incentive Plan (the “2005 Plan”) and, subsequently, have approved amendments to increase the number of issuable shares under the 2005 Plan. Under the 2005 Plan, employees, directors, consultants and other individuals who provide services to the Company may be granted awards in the form of stock options, stock appreciation rights, restricted stock, RSUs or deferred stock units. Up to 3,550,000 shares of the Company’s common stock may be issued in respect of awards under the 2005 Plan, as amended, with no more than 2,250,000 of those shares permitted to be issued in respect of restricted stock, RSUs, or deferred stock units granted under the 2005 Plan. Awards of stock options to purchase the Company’s common stock will have exercise prices as determined by the Compensation Committee of the Board of Directors but such exercise prices may not be lower than the fair market value of the stock on the date of grant.

No stock options have been granted by the Company with an exercise price less than the fair market value of the Company’s common stock on the date of grant for any of the periods presented. The majority of the stock options issued under the 2005 Plan vest

14

ratably over four-year periods and generally expire ten years from the date of grant, and restricted stock and time-based RSU awards issued under the 2005 Plan generally have restrictions that lapse ratably over periods ranging from one to four years however, awards with respect to up to 177,500 shares of our common stock may be granted under the 2005 Plan with a vesting period of less than one year. Performance-based awards issued under the 2005 Plan generally vest based upon the achievement of pre-established performance goals over a specified three-year period. The number of shares of our common stock that may be earned in respect of performance-based awards may be greater or less than the target number of shares granted based on the actual performance achieved. The non-executive chairman of the Company’s Board of Directors is granted 6,000 shares of restricted stock on an annual basis and each non-employee director, other than the non-executive chairman, and Christopher B. Morgan, of the Company’s Board of Directors is eligible for a grant of 4,000 shares of restricted stock on an annual basis, in each case that will generally vest one year from the date of grant. The Company issues new shares of common stock upon exercise of vested stock options. As of May4, 2019, there were 834,231 shares of the Company’s common stock available for grants of awards under the 2005 Plan.

Stock option activity for all plans was as follows:

	Outstanding Stock Options (in thousands)			Weighted Average Exercise Price		Weighted Average Remaining Life		Aggregate Intrinsic Value (in thousands)
Balance as of February 2, 2019	439			$	6.06
Granted	45			2.33
Exercised		—			—
Forfeited		(41	)	4.17
Expired		—			—
Balance as of May 4, 2019		443		$	5.85	8.3			—
Exercisable as of May 4, 2019	161			$	9.75		6.7		—

The following table summarizes information about stock options outstanding as of May 4, 2019:

	Stock Options Outstanding					Stock Options Exercisable
Range of Exercise Prices	Number Outstanding (in thousands)	Weighted Average Remaining Life		Weighted Average Exercise Price		Number Exercisable (in thousands)		Weighted Average Exercise Price
$ 2.33 to $  5.00	237		9.2	$	2.63		43	$	2.65
5.01 to   10.00	134		8.3		6.32	48			7.49
10.01 to   31.38	72		5.2		15.53	70			15.69
$ 2.33 to $31.38	443		8.3	$	5.85		161	$	9.75

The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes grants of 113,326 PRSUs which is the number of shares of common stock that would be delivered upon vesting assuming that the target level of performance is achieved.  If performance was achieved at the maximum level, 226,652 shares of common stock would be delivered in respect of such PRSU’s.  

	Outstanding Restricted Shares (in thousands)			Weighted Average Grant Date Fair Value
Unvested as of February 2, 2019		606		$	3.34
Granted		75			2.45
Vested		(64	)		2.72
Forfeited		(100	)		2.68
Unvested as of May 4, 2019		517		$	3.26

15

15. RECENT ACCOUNTING PRONOUNCEMENTS

Adopted

  In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to hereafter as ASC 842. ASC 842 affects any entity that enters into a lease, as that term is defined, and its guidance supersedes Topic 840, Leases. As it substantively relates to the Company, ASC 842 requires lessees to recognize a right-of-use asset (“ROU asset”) and a lease liability, initially measured at the present value of the lease payments, in the consolidated balance sheet.

On February 3, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements in effect at the beginning of the period of adoption. Results for periods beginning February 3, 2019 are presented under ASC 842, and prior period amounts were not restated and continue to be reported under the Company’s historical method of lease accounting, ASC 840, Leases. Adoption of ASC 842 had a material impact of the Company’s balance sheet as the result of recognizing ROU assets and lease liabilities for operating leases. There was no material impact to our consolidated statement of operations or cash flows and there was no impact to covenant compliance under our current debt agreements. Accounting for finance leases remained substantially unchanged. For leases that commenced prior to the effective date of ASC 842 the Company adopted practical expedients that allowed for retention of its previous assessment of the following: (i) whether a contract contained a lease, (ii) lease classification and (iii) initial direct costs. The Company also elected not to recognize ROU assets and lease liabilities for leases with a term of 12 months or less and to account for leases which have both lease and non-lease components as a single component.

At the date of adoption, the Company recorded operating lease ROU assets of $135 million, operating lease liabilities of $159 million, primarily related to its retail real estate, distribution center and corporate office and a $2.6 million adjustment to accumulated deficit resulting from the impairment of certain operating lease ROU assets. Refer to Note 8. Leases for additional disclosures required by ASC 842.

The Company determines if an arrangement is a lease at inception. ROU assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement of the lease based on the net present value of the fixed lease payments over the lease term.  The lease term includes options to extend or terminate the lease when it is reasonably certain that we will exercise the option. ROU assets include prepaid lease payments, lease incentives received and capitalized lease costs. As the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on information available at the lease commencement date to determine the present value of lease payments. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense, while the expense for finance leases is recognized as depreciation and interest expense over the lease term.  

In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred over the non-cancellable term of the cloud computing arrangements plus any optional renewal periods (1) that are reasonably certain to be exercised by the customer or (2) for which exercise of the renewal option is controlled by the cloud service provider. The effective date of this pronouncement is for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and early adoption is permitted. The Company adopted ASU 2018-15 effective February 3, 2019, and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

16. COMMITMENTS AND CONTINGENCIES

From time to time, the Company is named as a defendant in legal actions arising from normal business activities. Litigation is inherently unpredictable, and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, the Company does not believe that the resolution of any pending action will have a material adverse effect on its financial position, results of operations or liquidity.

The Company has recently gained access to inspect inventory subject to a potential loss that occurred while the inventory was in transit to the Company’s distribution center. While still in the process of evaluating the inventory, the Company believes that it has insurance coverage in place to cover any potential loss, should such a loss occur.

16

17. SEGMENT AND ENTERPRISE WIDE DISCLOSURES

Operating Segment. For purposes of the disclosure requirements for segments of a business enterprise, the Company has determined that its business is comprised of one operating segment: the design, manufacture and sale of maternity apparel and related accessories. While the Company offers a wide range of products for sale, the substantial portion of its products are initially distributed through the same distribution facilities, many of the Company’s products are manufactured at common contract manufacturer production facilities, the Company’s products are marketed through a common marketing department, and these products are sold to a similar customer base consisting of expectant mothers.

Geographic Information. Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Net Sales
United States	$	90,646	$	98,250
Foreign		3,567		4,977

	May 4, 2019		February 2, 2019
Long-Lived Assets
United States	$	49,995	$	51,068
Foreign		1,078		1,228

Major Customers. For the periods presented, the Company did not have any one customer who represented more than 10% of its net sales.

18. INTEREST EXPENSE, NET

Interest expense, net was comprised of the following (in thousands):

	Three Months Ended
	May 4, 2019			May 5, 2018
Interest expense	$	1,416		$	1,158
Interest income		(1	)		(1	)
Interest expense, net	$	1,415		$	1,157

17

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

We operate on a 52/53-week fiscal year ending on the Saturday nearest January 31 of each year. References in this discussion to our fiscal 2019 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 3, 2019 and will end February 1, 2020. References to our fiscal 2018 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 4, 2018 and ended February 2, 2019.

Forward-Looking Statements

Some of the information in this report, including the information incorporated by reference (as well as information included in oral statements or other written statements made or to be made by us), contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The forward-looking statements involve a number of risks and uncertainties. The following factors, among others, in some cases have affected, and in the future, could cause our actual results, performance, achievements or industry results to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements. These factors include, but are not limited to: the strength or weakness of the retail industry in general and of apparel purchases in particular, our ability to successfully manage our various business initiatives, the success of our international business and its expansion, our ability to successfully manage, retain and expand our leased department and international franchise relationships and marketing partnerships, future sales trends in our various sales channels, unusual weather patterns, changes in consumer spending patterns, raw material price increases, overall economic conditions and other factors affecting consumer confidence, demographics and other macroeconomic factors that may impact the level of spending for maternity apparel (such as fluctuations in pregnancy rates and birth rates), expense savings initiatives, our ability to anticipate and respond to fashion trends and consumer preferences, unanticipated fluctuations in our operating results, the impact of competition and fluctuations in the price, availability and quality of raw materials and contracted products, availability of suitable store locations, continued availability of capital through equity and debt financing, our ability to hire, develop and retain senior management and sales associates, our ability to develop and source merchandise, our ability to receive production from foreign sources on a timely basis, our compliance with applicable financial and other covenants under our financing arrangements, the trading liquidity of our common stock, changes in market interest rates, our compliance with certain tax incentive and abatement programs, war or acts of terrorism and other factors referenced in our Annual Report on Form 10-K, including those set forth under the caption “Risk Factors.”

In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties and other factors. Accordingly, any forward-looking statements included in this report do not purport to be predictions of future events or circumstances and may not be realized. Forward-looking statements can be identified by, among other things, the use of forward-looking terms such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “pro forma,” “anticipates,” “intends,” “continues,” “could,” “estimates,” “plans,” “potential,” “predicts,” “goal,” “objective,” or the negative of any of these terms, or comparable terminology, or by discussions of our outlook, plans, goals, strategy or intentions. Forward-looking statements speak only as of the date made. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the SEC, we assume no obligation to update any of these forward-looking statements to reflect actual results, changes in assumptions or changes in other factors affecting these forward-looking statements.

Presentation of Financial Information

Comparable sales figures represent sales at retail locations (which does not include licensed brand or international franchise relationships) that have been in operation by us for at least 13 full months, as well as Internet sales. Our comparable sales figures generally do not include: 1) retail locations which change location type or format, 2) retail locations which are expanded, contracted or relocated if the square footage of the retail location has changed by 20% or more, or, if in the judgment of management, such expansion, contraction or relocation materially alters the comparability of the retail location (either with respect to the manner of its operation or otherwise), 3) in the case of relocations only, retail locations which are not in the same immediate geographical vicinity (such as, without limitation, the same mall, the same part of a mall, or the same street) after the relocation, 4) retail locations that have temporarily closed for any reason for 30 days or more, or 5) retail locations which, in the judgment of management, have undergone other significant changes which materially alter the comparability of the retail location (either with respect to the manner of its operation or otherwise) (such as, for example only, in the case of closure of retail locations in connection with the cessation of a leased department relationship where the manner of operation of such retail location has been materially altered prior to closure, or in the case of construction in, on or near a retail location, which significantly interferes with the customer traffic, visibility or operation of a retail location). Comparable sales exclude the 53^rd week of sales for 53-week fiscal years. In the 52-week fiscal year subsequent to a 53-week fiscal year, we exclude the sales in the non-comparable week from the comparable sales calculation. There may be variations in the way in which other retailers calculate comparable sales. As a result, data in this quarterly report regarding our comparable sales may not be comparable to similar data made available by other retailers.

18

Use of Non-GAAP Measures

In assessing the performance of our business, we consider a variety of operational and financial measures. The key measures for determining how our business is performing are net income (loss) determined in accordance with GAAP (“net income (loss)”) and the corresponding net income (loss), (or earnings (loss)) per share (diluted), net income (loss) before certain charges or credits, when applicable, such as other charges, loss on extinguishment of debt, and certain infrequent income tax adjustments (“adjusted net income (loss)”) and the corresponding earnings (loss) per share (diluted), Adjusted EBITDA (as defined below), Adjusted EBITDA before other charges, net sales, and comparable sales. Adjusted EBITDA represents operating income (loss) before deduction for the following non-cash charges: 1) depreciation and amortization expense, 2) loss on impairment of tangible and intangible assets, 3) loss on disposal of assets, and 4) stock-based compensation expense.

Our management believes that each of the non-GAAP financial measures presented by us provides useful information about our results of operations and/or financial position to both investors and management. Each non-GAAP financial measure is provided because management believes it is an important measure of financial performance used in the retail industry to measure operating results, to determine the value of companies within the industry and to define standards for borrowing from institutional lenders. We use each of these non-GAAP financial measures as a measure of our performance. In addition, certain of our cash and equity incentive compensation plans are based on our level of achievement of Adjusted EBITDA before other charges, which is substantially identical to our non-GAAP financial measure of Adjusted EBITDA before certain other deductions.

We provide these various non-GAAP financial measures to investors to assist them in performing their analysis of our historical operating results. Each of these non-GAAP financial measures reflects a measure of our operating results before consideration of certain charges and consequently, none of these measures should be construed as an alternative to net income (loss) or operating income (loss) as an indicator of our operating performance, or as an alternative to cash flows from operating activities as a measure of our liquidity, as determined in accordance with GAAP. We may calculate each of these non-GAAP financial measures differently than other companies.

With respect to the non-GAAP financial measures discussed in Management’s Discussion and Analysis of Financial Condition and Results of Operations, we have provided reconciliations of the non-GAAP financial measures to the most directly comparable GAAP financial measures in this Quarterly Report.

Overview

We are the leading designer and retailer of maternity apparel in the United States with 998 retail locations, including 452 stores in the United States, Canada and Puerto Rico, and 546 leased departments located within department stores and baby specialty stores throughout North America. We also sell merchandise on the Internet, primarily through our Motherhood.com, APeaInThePod.com and Destinationmaternity.com websites. We also sell our merchandise through our Canadian website, MotherhoodCanada.ca, through Amazon.com in the United States, and through websites of certain of our retail partners, including Macys.com.  We have store franchise and product supply relationships in South Korea, Mexico and Israel. As of May 4, 2019, we have 184 international franchised locations, including 9 stand-alone stores operated under one of our retail nameplates and 175 shop-in-shop locations.

Management and Organizational Changes

We have engaged in a series of management and organizational changes over the last several years. Through these actions, we are attempting to identify further opportunities to become more profitable in the near future, by increasing both revenue and gross margins while reducing expenses. During the three months ended May 4, 2019 and May 5, 2018, we recognized $0.7 million and $0.3 million, respectively, of charges related to management and organizational changes.

Proxy Solicitation

In the first quarter of fiscal 2018, we received notification from a stockholder group of the nomination of a slate of alternative nominees for election to our Board of Directors at the 2018 Annual Meeting of Stockholders that was held on May 23, 2018 (the “Proxy Solicitation”). At our 2018 Annual Meeting of Stockholders the Company’s stockholders replaced the incumbent board in its entirety and elected Holly N. Alden, Christopher B. Morgan, Marla A. Ryan and Anne-Charlotte Windal as our new Board of Directors. During the three months ended May 5, 2018, we incurred $0.9 million of charges related to the Proxy Solicitation.

19

First Quarter Fiscal 2019 Financial Results

• Net sales for the first quarter of fiscal 2019 decreased 8.7% to $94.2 million from $103.2 million for the first quarter of fiscal 2018.

- Comparable sales for the first quarter of fiscal 2019 decreased 7.2%, compared to a comparable sales decrease of 0.1% for the first quarter of fiscal 2018.

• Net income for the first quarter of fiscal 2019 was $0.1 million, or $0.01 per share (diluted), compared to net income of $0.2 million, or $0.02 per share (diluted), for the first quarter of fiscal 2018.

- Net income the first quarter of fiscal 2019 includes a $0.5 million of other charges, net of tax, related to management and organizational changes.  Net income for the first quarter of fiscal 2018 includes other charges of $0.9 million, net of tax.

and a $0.1 million non-cash income tax benefit related to a change in the valuation allowance against net deferred tax assets.

- Adjusted net income for the first quarter of fiscal 2019 was $0.6 million, or $0.04 per share (diluted), compared to the

       comparably adjusted net income for the first quarter of fiscal 2018 of $1.0 million, or $0.07 per share (diluted).

• Adjusted EBITDA was $6.0 million for the first quarter of fiscal 2019, compared to $6.7 million of Adjusted EBITDA for the first quarter of fiscal 2018.

- Adjusted EBITDA before other charges was $6.7 million for the first quarter of fiscal 2019, a decrease of 15% compared to $7.9 million of Adjusted EBITDA before other charges for the first quarter of fiscal 2018.

Results of Operations

The following table sets forth certain operating data as a percentage of net sales and as a percentage change for the three months ended May 4, 2019 and May 5, 2018:

	% of Net Sales (1)						% Change Period to Period Favorable (Unfavorable)
	Three Months Ended						Three Months Ended May 4, 2019 vs.
	May 4, 2019			May 5, 2018			May 5, 2018
Net sales		100.0	%		100.0	%		(8.7	)%
Cost of goods sold (2)		45.2			46.3			10.9
Gross profit		54.8			53.7			(6.9	)
Selling, general and administrative expenses (3)		51.5			50.2			6.5
Store closing, asset impairment and disposal expenses		0.9			0.9			10.3
Other charges, net		0.7			1.1			42.4
Operating income		1.8			1.5			10.4
Interest expense, net		1.5			1.1			(22.3	)
Income before income taxes		0.2			0.3			(40.4	)
Income tax provision		0.0			0.1			44.6
Net income		0.1	%		0.2	%		(39.3	)%

(1) Components may not add to the exact total amount due to rounding.

(2) “Cost of goods sold” includes merchandise costs (including customs duty expenses), expenses related to inventory shrinkage, product related corporate expenses (including expenses related to our payroll, benefit costs and operating expenses of our buying departments), inventory reserves (including lower of cost or net realizable value reserves), inbound freight charges, purchasing and receiving costs, inspection costs, distribution center costs (including occupancy expenses and equipment depreciation), internal transfer costs, and the other costs of our distribution network, partially offset by the allocable amount of our Grow NJ benefit.

(3) “Selling, general and administrative expenses” includes advertising and marketing expenses, corporate administrative expenses, corporate headquarters occupancy expenses, store expenses (including store payroll and store occupancy expenses), and store opening expenses, partially offset by the allocable amount of our Grow NJ benefit.

20

The following tables set forth certain information concerning the number of our retail locations and international franchised locations for the periods indicated.

	Three Months Ended
	May 4, 2019									May 5, 2018
Retail Locations	Stores			Leased Departments			Total Retail Locations			Stores			Leased Departments			Total Retail Locations
Beginning of period		458			554			1,012			487			637			1,124
Opened		1			—			1			—			—			—
Closed		(7	)		(8	)		(15	)		(3	)		(3	)		(6	)
End of period		452			546			998			484			634			1,118

	Three Months Ended
	May 4, 2019						May 5, 2018
International Franchised Locations	Stores		Shop-in- Shop Locations		Total International Franchised Locations		Stores			Shop-in- Shop Locations		Total International Franchised Locations
Beginning of period		9		175		184		15			173		188
Opened		—		—		—		—			—		—
Closed		—		—		—		(2	)		—		(2	)
End of period		9		175		184		13			173		186

Three Months Ended May 4, 2019 and May 5, 2018

Net Sales.    Our net sales for the first quarter of fiscal 2019 decreased by 8.7%, or $9.0 million, to $94.2 million from $103.2 million for the first quarter of fiscal 2018. Comparable sales for the first quarter of fiscal 2019 decreased 7.2%, compared to a comparable sales decrease of 0.1% for the first quarter of fiscal 2018. The decrease in total reported sales for the first quarter of fiscal 2019 compared to the first quarter of fiscal 2018, resulted primarily from the closure of underperforming retail and lease locations and a decline in store traffic, partially offset by an increase is average selling price.

Gross Profit.    Our gross profit for the first quarter of fiscal 2019 decreased by 6.9%, or $3.8 million, to $51.6 million from $55.4 million for the first quarter of fiscal 2018, and our gross profit as a percentage of net sales (gross margin) for the first quarter of fiscal 2019, was 54.8% compared to 53.7% for the first quarter of fiscal 2018. The decrease in gross profit for the first quarter of fiscal 2019 compared to the first quarter of fiscal 2018, was due to our lower sales volume as a result of the closure of underperforming retail and lease locations and a decline in comparable store sales. The year-over-year increase in gross margin is primarily a result of a decrease in markdown and promotional activity.

Selling, General and Administrative Expenses.    Our selling, general and administrative expenses for the first quarter of fiscal 2019 decreased by 6.5%, or $3.4 million, to $48.5 million from $51.9 million for the first quarter of fiscal 2018. As a percentage of net sales, selling, general and administrative expenses increased to 51.5% for the first quarter of fiscal 2019 from 50.2% for the first quarter of fiscal 2018. This decrease in expense for the quarter primarily reflects reductions in employee costs and occupancy expenses resulting from the closure of underperforming stores and ongoing expense reduction initiatives. The increase in expense as a percent of sales reflects the unfavorable leverage from our decreased sales due to the relatively fixed nature of our expenses.

Store Closing, Asset Impairment and Asset Disposal Expenses.   Our store closing, asset impairment and asset disposal expenses, including $0.4 million in right-of-use asset impairment, was $0.9 million for the first quarter of fiscal 2019 compared to $1.0 million for the first quarter of fiscal 2018.

Other Charges, Net.    In the first quarter of fiscal 2019, we incurred other charges of $0.7 million which is primarily consulting fees and personnel costs related to our management and organizational change initiatives. In the first quarter of fiscal 2018 we incurred other charges of $1.1 million which includes $0.8 million for legal and advisory fees related to the proxy solicitation and $0.3 million in personnel costs related to our management and organizational change initiatives.

Operating Income.    We had operating income of $1.6 million for the first quarter of fiscal 2019, compared to operating income of $1.4 million for the first quarter of fiscal 2018. The $0.2 million increase in operating income is the result of a $3.4 million decrease in selling, general and administrative expenses and a $0.5 million decrease in other charges partially offset by a $3.8 million reduction in gross profit.

21

Interest Expense, Net.    Net interest expense of $1.4 million for the first quarter of fiscal 2019 was $0.2 million higher than the first quarter of fiscal 2018. This increase is the result of an increase in both interest rates and our average debt outstanding.

Income Tax Provision.    For the first quarter of fiscal 2019 and fiscal 2018, our income tax provision was $31,000 and $56,000, respectively.  These tax provisions primarily represent minimum state income taxes.  Since fiscal 2016, we have been recording full valuation allowances against our deferred tax assets, primarily net operating loss carryforwards.  

Net Income.    Net income for the first quarter of fiscal 2019 was $0.1 million, or $0.01 per share (diluted), compared to net income of $0.2 million, or $0.02 per share (diluted), for the first quarter of fiscal 2018. Net income for the first quarter of fiscal 2019 includes other charges of $0.5 million, net of tax, related to management and organizational changes. Net income for the first quarter of fiscal 2018 includes a $0.1 million non-cash income tax charge related to a change in the valuation allowance against deferred tax assets and other charges of $0.8 million, net of tax.

Our average diluted shares outstanding of 13.9 million was comparable to the 14.0 million average diluted shares for the first quarter of fiscal 2018.

The following is a reconciliation of net income and net income per share (diluted) (“Diluted EPS”) to adjusted net income and adjusted Diluted EPS for the three months ended May 4, 2019 and May 5, 2018 (in thousands, except per share amounts):

	Three Months Ended
	May 4, 2019							May 5, 2018
	Net Income			Diluted Shares		Diluted EPS		Net Income			Diluted Shares		Diluted EPS
As reported	$	130			13,901	$	0.01	$	214			13,963	$	0.02
Other charges		662			—				1,150			—
Income tax effect of other charges (1)		(154	)		—				(273	)		—
Deferred tax valuation allowance related to    cumulative losses		(30	)		—				(67	)		—
As adjusted	$	607			13,901	$	0.04	$	1,024			13,963	$	0.07

(1) Income tax effect of other charges represents the differences in income tax provision calculated with and without the specified items of pretax expense or (income).

The following is a reconciliation of net income to Adjusted EBITDA and Adjusted EBITDA before other charges for the first quarter of fiscal 2019 and 2018 (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Net income	$	130	$	214
Income tax provision		31		56
Interest expense, net		1,415		1,157
Operating income		1,576		1,427
Depreciation and amortization expense		3,553		4,050
Loss on impairment of long-lived assets		562		887
Loss on disposal of assets		188		13
Stock-based compensation expense		144		328
Adjusted EBITDA		6,023		6,705
Other charges		662		1,150
Adjusted EBITDA before other charges	$	6,685	$	7,855

Seasonality

Our business, like that of many other retailers, is seasonal. Our quarterly net sales have historically been highest in the peak Spring selling season, which will generally occur during the calendar months of March through May, in our first fiscal quarter and the early part of our third fiscal quarter. Given the typically higher sales level in that timeframe and the relatively fixed nature of most of our operating expenses, we have historically generated a significant percentage of our full year operating income during this period. Results for any quarter are not necessarily indicative of the results that may be achieved for a full fiscal year. Quarterly results may be

22

subject to substantial fluctuation depending upon, among other things, increases or decreases in comparable sales, the timing of new store openings and closings, new leased department openings and closings, net sales and profitability contributed by new stores and leased departments, the timing of the fulfillment of purchase orders under our product and license arrangements, adverse weather conditions, shifts in the timing of certain holidays and promotions, changes in inventory and production levels and the timing of deliveries of inventory, and changes in our merchandise mix.

Liquidity and Capital Resources

Our cash needs have primarily been for 1) capital expenditures, including (i) leasehold improvements, fixtures and equipment for new stores, store relocations and remodels of our existing stores, and (ii) investment in information systems and technology, 2) debt service, including principal prepayments, and 3) working capital, including inventory to support our business. We have historically financed our capital requirements from cash flows from operations, borrowings under our credit facilities or available cash balances.

Cash and cash equivalents were unchanged during the first quarter of fiscal 2019, compared to an increase of $0.4 million for the first quarter of fiscal 2018.

Cash used in operations was $4.6 million for the first quarter of fiscal 2019, as compared to $2.5 million of cash used in operations for the first quarter of fiscal 2018. This increase of approximately $2.1 million in cash used in operations compared to the prior period is primarily the result of a $2.8 million decrease in accrued expenses in fiscal 2019 compared to fiscal 2018 related to the amount and timing of payments of employee compensation and related benefits.  Our working capital changes, quarterly net income and cash flow adjustments may fluctuate significantly, and net cash provided by or used in operating activities for any interim period is not necessarily indicative of the results that may be achieved for a full fiscal year.

During the first quarter of fiscal 2019, we borrowed $5.8 million against our line of credit to provide working capital, make periodic payments on our equipment loans and fund capital expenditures. Capital expenditures for the first quarter of fiscal 2019 totaled $2.5 million, including $0.3 million for improvements to new and existing stores and $2.2 million for information systems.  We expect to use borrowings under our existing $50.0 million senior secured revolving credit facility to fund a portion of our capital requirements from time to time during the remainder of our 2019 fiscal year.  

On February 1, 2018 (the “Closing Date”) we entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25.0 million (the “Term Loan”).  On the Closing Date we borrowed $22.5 million against the Term Loan. In July 2018, we borrowed an additional $2.5 million under our Term Loan increasing the balance to $25.0 million, the full amount permitted to be outstanding under the agreement.

The Term Loan matures on January 31, 2023 (the “Maturity Date”).  There is a minimum excess availability requirement of the greater of 10% of the combined loan cap, as defined in the Term Loan Agreement, or $7.0 million. The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.  We began to make minimum payments of $0.3 million each quarter commencing on July 31, 2018, with the remaining outstanding balance payable on the Maturity Date.  The Term Loan can be prepaid at our option, subject to certain restrictions and subject to a prepayment premium as follows: 1) if prepayment occurs on or prior to the third anniversary of the Closing Date, the greater of a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment, and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date.      

In conjunction with entering into the Term Loan Agreement, on February 1, 2018 we also amended and restated our credit facility (the “Credit Facility”).  This amendment, among other things, reduced the borrowing amount under the Credit Facility from $70.0 million to $50.0 million, extended the Termination Date to January 31, 2023 and reduced or eliminated certain availability reserves.  

23

As of May 4, 2019, we had $26.2 million in borrowings and $6.3 million in letters of credit outstanding under the Credit Facility with $10.1 million of availability. As of May 5, 2018, we had $15.2 million of borrowings and $7.3 million in letters of credit with $20.2 million of availability. For the first quarter of fiscal 2019, our borrowings had a weighted interest rate of 4.53% per annum, our average level of borrowing was $27.5 million and our maximum borrowing at any time was $32.3 million.  For the first quarter of fiscal 2018, our borrowings had a weighted interest rate of 3.60% per annum our average level of direct borrowings was $19.4 million and our maximum borrowings at any time were $27.4 million.

On February 22, 2019, the Company entered into a 24-month, $1.8 million software development financing arrangement. The note has monthly payments of $81,648 with an interest rate of 8.16%. As of May 4, 2019, there was $1.6 million of principal outstanding.  

As of May 4, 2019 and May 5, 2018, there was $2.1 million and $5.3 million, respectively, outstanding under a five-year equipment financing arrangement with our Credit Facility lender. The equipment note bears annual interest at 3.38%, with payments of $0.3 million (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at our distribution facility in Florence, New Jersey.

On June 6, 2017, we received $3.4 million in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software.  Monthly payments under the leaseback arrangement are $0.1 million for the first 24 months and $48,000 for months 25 to 36.  At the end of the leaseback term, we have the option to extend the financing for an additional year or repurchase the property for a price to be agreed upon. All proceeds from the transaction were used to prepay a portion of our Term Loan.  As of May 4, 2019 and May 5, 2018, there was $1.1 million and $2.3 million, respectively, of principal outstanding under the arrangement.

In connection with the relocation of our corporate headquarters and our distribution operations from Philadelphia, Pennsylvania to southern New Jersey, the Board of the NJEDA approved us for an incentive package of up to $4.0 million in annual benefits under Grow NJ in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The annual benefit amount available to us is based on an average of eligible jobs within the state and is expected to significantly exceed our annual income tax liability to New Jersey. In order to maximize the realizable value of our incentive package we have an agreement with a third party to sell up to 100% of the annual income tax credits awarded to us. For fiscal 2018 we qualified for $3.0 million in tax credits for which we expect to realize $2.7 million in cash proceeds during fiscal 2019.  In December 2018 we received $2.8 million in proceeds, net of costs, from the sale of the tax credits we earned in fiscal 2017. For fiscal 2019 our average eligible jobs are expected to be lower than in fiscal 2018 and we project that we will receive approximately $2.9 million of transferrable tax credits with a pretax realizable value of approximately $2.6 million, subject to our compliance with the requirements under our Grow NJ award. Cost reductions from lower headcount are expected to more than offset any decline in the amount realized from our incentive package.

Based on our current operating plan, our management believes that our current cash and working capital positions, expected operating cash flows and available borrowing capacity will be sufficient to fund our cash requirements for working capital and capital expenditures for at least the next 12 months. We have based this belief on assumptions that we believe are reasonable but may not be realized due to a variety of factors including lower than anticipated net sales or gross margins, increased expenses, continued or declining levels of economic or retail industry conditions, or other events, including those factors discussed in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended February 2, 2019. As a result, we could use our available capital resources sooner than we currently expect. Furthermore, our operating plan may change, and we may need additional funds sooner than planned. If we are unable to obtain required funds from the aforementioned sources, we will likely need to seek other sources of financing which may not be on favorable terms. as well as defer, reduce or eliminate planned expenditures, which would likely impair our growth prospects and could otherwise negatively impact our business.

Contractual Obligations

There have been no material changes since February 2, 2019, outside of the ordinary course of business, to contractual obligations specified in the table of contractual obligations and commercial commitments in the section “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Annual Report on Form 10-K for the fiscal year ended February 2, 2019.

Off-Balance Sheet Financing Arrangements

We do not have any material off-balance sheet financing arrangements.

24

Critical Accounting Policies and Estimates

Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States. These generally accepted accounting principles require management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of net sales and expenses during the reporting period. Our critical accounting policies are described in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the fiscal year ended February 2, 2019. In conjunction with the adoption of ASU No. 2016-02, Leases (Topic 842) on February 3, 2019, we began recognizing a right-of-use asset and a lease liability, initially measured at the present value of the lease payments in the consolidated balance sheet. As of May 4, 2019, there were no other material changes in, or additions to, our critical accounting policies or in the assumptions or estimates we used to prepare the financial information appearing in this report.

Recent Accounting Pronouncements

          Refer to Note 15 to the Consolidated Financial Statements for a description of recent accounting pronouncements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are exposed to market risk from changes in interest rates. We have not entered into any market sensitive instruments for trading purposes. The analysis below presents the sensitivity of the market value of our financial instruments to selected changes in market interest rates. The range of changes presented reflects our view of changes that are reasonably possible over a one-year period.

As of May 4, 2019, we had cash and cash equivalents of $1.2 million. Our cash equivalents consist of investments in money market funds that bear interest at variable rates. A change in market interest rates earned on our investments impacts the interest income and cash flows but does not materially impact the fair market value of the financial instruments. Due to the low balance, average maturity and conservative nature of our investment portfolio, we believe a sudden change in interest rates would not have a material effect on the value of our investment portfolio. The impact on our future interest income resulting from changes in investment yields will depend largely on the gross amount of our investment portfolio at that time. However, based upon the conservative nature of our investment portfolio and current experience, we do not believe a decrease in investment yields would have a material negative effect on our interest income.

As of May 4, 2019, our indebtedness consisted of the $23.8 million outstanding under our Term Loan, the $4.9 million of principal balances of our equipment notes, and $26.2 million outstanding under the Credit Facility. All of our indebtedness is denominated in United States dollars. The fair value of our indebtedness is referred to as the “debt value.” The equipment notes bear interest at a weighted fixed rate of 7.16%. Although a change in market interest rates would not affect the interest incurred or cash flow related to this fixed rate portion of our indebtedness, the debt value would be affected.

The Term Loan carries a variable interest rate that is tied to market indices with a minimum annual rate of 9.0%. The sensitivity analysis as it relates to this portion of our debt portfolio assumes an instantaneous 100 basis point move in interest rates above and below the minimum threshold, with all other variables held constant. The debt value of the Term Loan is approximately $23.8 million. A 100-basis point increase in market interest rates above the minimum threshold would result in additional annual interest expense on the Term Loan of approximately $0.2 million. A 100-basis point decline in market interest rates below the minimum threshold would have no effect on our annual interest expense on the Term Loan.

Our Credit Facility has variable interest rates that are tied to market indices. As of May 4, 2019, we had $26.2 million of direct borrowings and $6.3 million of letters of credit outstanding under our Credit Facility. As of May 4, 2019, borrowings under the Credit Facility would have resulted in interest at a rate between 3.94% and 6.00% per annum. Interest on any future borrowings under the Credit Facility would, to the extent of outstanding borrowings, be affected by changes in market interest rates. A change in market interest rates on the variable rate portion of our indebtedness would impact the interest expense incurred and cash flows.

The sensitivity analysis as it relates to the fixed rate portion of our indebtedness assumes an instantaneous 100 basis point move in interest rates from their levels as of May 4, 2019, with all other variables held constant. A 100-basis point increase in market interest rates would result in a decrease in the value of the debt by approximately $25,000 as of May 4, 2019. A 100-basis point decline in market interest rates would cause the debt value to increase by approximately $25,000 as of May 4, 2019.

25

Item 4. Controls and Procedures

Disclosure Controls and Procedures

Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that are filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. These disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed under the Exchange Act is accumulated and communicated to our management on a timely basis to allow decisions regarding required disclosure. We evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of May 4, 2019. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that as of May 4, 2019, these controls and procedures were effective.

Internal Control over Financial Reporting

There have been no changes in internal control over financial reporting identified in connection with the foregoing evaluation that occurred during the fiscal quarter ended May 4, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

26

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are named as a defendant in legal actions arising from our normal business activities. Litigation is inherently unpredictable, and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, we do not believe that the resolution of any pending action will have a material adverse effect on our financial position, results of operations or liquidity.

Item 1A. Risk Factors

In addition to the other information set forth in this Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended February 2, 2019. The risks described in our Annual report on Form 10-K are not the only risks that we face. Additional risks not presently known to us or that we do not currently consider significant may also have an adverse effect on us. If any of the risks actually occur, our business, results of operations, cash flows or financial condition could be adversely impacted.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information about purchases by us during the three-month period February 3, 2019 to May 4, 2019of our Common Stock that is registered by us pursuant to Section 12 of the Exchange Act:

Period	Total Number of Shares Purchased (1)		Average Price Paid per Share		Total Number of Shares Purchased as Part of a Publicly Announced Program (2)		Maximum Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (2)
February 3 to March 2, 2019		—	$	—		—		—
March 3 to April 6, 2019		3,022		2.18		—		—
April 7 to May 4, 2019		12,589		2.17		—		—
Total		15,611	$	2.17		—		—

(1) Represents shares of Common Stock reacquired by us from certain employees to satisfy income tax withholding obligations for such employees in connection with restricted stock awards that vested during the period.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

27

Item 6. Exhibits

Exhibit No.		Description
3.1		Restated Certificate of Incorporation of the Company (Exhibit 3.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2008, filed on December 15, 2008).
3.2		Bylaws of the Company, effective December 22, 2016 (Exhibit 3.2 to the Company’s Annual Report on Form 10-K for the fiscal year ended February 3, 2018, filed on April 19, 2018).
31.1	*	Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	*	Certification of the Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	**	Certification of the Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	**	Certification of the Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	*	XBRL Instance Document
101.SCH	*	XBRL Taxonomy Extension Schema Document
101.CAL	*	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	*	XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	*	XBRL Taxonomy Extension Label Linkbase Document
101.PRE	*	XBRL Taxonomy Extension Presentation Linkbase Document

* filed herewith

** furnished herewith

28

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Destination Maternity Corporation
Date: June 12, 2019	By:	/s/ MARLA A. RYAN
		Marla A. Ryan
		Chief Executive Officer
Date: June 12, 2019	By:	/s/ DAVE J. HELKEY
		Dave J. Helkey
		Chief Operating Officer & Chief Financial Officer

29

EX-31.1

Exhibit 31.1

SARBANES-OXLEY

SECTION 302 CERTIFICATION

I, Marla A. Ryan, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Destination Maternity Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

June 12, 2019	/s/ MARLA A. RYAN
Date	Marla A. Ryan
	Chief Executive Officer

EX-31.2

Exhibit 31.2

SARBANES-OXLEY

SECTION 302 CERTIFICATION

I, Dave J. Helkey, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Destination Maternity Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors:

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

June 12, 2019	/s/ DAVE J. HELKEY
Date	Dave J. Helkey
	Chief Operating Officer & Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES–OXLEY ACT OF 2002

In connection with the Quarterly Report of Destination Maternity Corporation (the “Company”) on Form 10-Q for the period ended May 4, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Marla A. Ryan, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ MARLA A. RYAN

Marla A. Ryan

Chief Executive Officer

June 12, 2019

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES–OXLEY ACT OF 2002

In connection with the Quarterly Report of Destination Maternity Corporation (the “Company”) on Form 10-Q for the period ended May 4, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dave J. Helkey, Chief Operating Officer & Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ DAVE J. HELKEY

Dave J. Helkey

Chief Operating Officer & Chief Financial Officer

June 12, 2019

XML

Document and Entity Information - shares	3 Months Ended
	May 04, 2019	Jun. 03, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	May 04, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Trading Symbol	DEST
Entity Registrant Name	Destination Maternity Corp
Entity Central Index Key	0000896985
Current Fiscal Year End Date	--02-01
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		14,339,786

XML

CONSOLIDATED BALANCE SHEETS (unaudited) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Current assets:
Cash and cash equivalents	$ 1,193	$ 1,154
Trade receivables, net	8,807	7,945
Inventories	72,133	70,872
Prepaid expenses and other current assets	9,855	9,407
Total current assets	91,988	89,378
Property and equipment, net of accumulated depreciation and amortization of $108,556 and $106,479	50,510	51,483
Operating lease assets	128,065
Deferred income taxes	3,314	2,671
Other non-current assets	1,918	2,642
Total assets	275,795	146,174
Current liabilities:
Line of credit borrowings	26,200	20,400
Current portion of long-term debt	4,257	4,372
Accounts payable	21,355	21,854
Operating lease liabilities	32,327
Accrued expenses and other current liabilities	24,608	31,056
Total current liabilities	108,747	77,682
Long-term debt	22,294	21,784
Operating lease and other non-current liabilities	119,938	19,557
Total liabilities	250,979	119,023
Commitments and contingencies (Note 16)
Stockholders’ equity:
Preferred stock, 1,656,381 shares authorized, none outstanding
Common stock, $.01 par value; 20,000,000 shares authorized, 14,375,658 and 14,416,500 shares issued and outstanding	144	144
Additional paid-in capital	107,785	107,675
Accumulated deficit	(83,039)	(80,594)
Accumulated other comprehensive loss	(74)	(74)
Total stockholders’ equity	24,816	27,151
Total liabilities and stockholders’ equity	$ 275,795	$ 146,174

XML

CONSOLIDATED BALANCE SHEETS (unaudited) (Parenthetical) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Statement Of Financial Position [Abstract]
Property and equipment, accumulated depreciation and amortization	$ 108,556	$ 106,479
Preferred stock, shares authorized	1,656,381	1,656,381
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	20,000,000	20,000,000
Common stock, shares issued	14,375,658	14,416,500
Common stock, shares outstanding	14,375,658	14,416,500

XML

CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Income Statement [Abstract]
Net sales	$ 94,213	$ 103,227
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Cost of goods sold	$ 42,616	$ 47,824
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Gross profit	$ 51,597	$ 55,403
Selling, general and administrative expenses	48,490	51,857
Store closing, asset impairment and asset disposal expenses	869	969
Other charges	662	1,150
Operating income	1,576	1,427
Interest expense, net	1,415	1,157
Income before income taxes	161	270
Income tax provision	31	56
Net income	$ 130	$ 214
Net income per share— Basic	$ 0.01	$ 0.02
Average shares outstanding— Basic	13,825	13,839
Net income per share— Diluted	$ 0.01	$ 0.02
Average shares outstanding— Diluted	13,901	13,963

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 130	$ 214
Comprehensive income	$ 130	$ 214

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning Balance at Feb. 03, 2018	$ 40,668	$ 147	$ 106,865	$ (66,274)	$ (70)
Beginning Balance, shares at Feb. 03, 2018		14,684
Net income	214			214
Dividends forfeited	1			1
Stock-based compensation	328	$ 4	324
Stock-based compensation, shares		383
Repurchase and retirement of common stock	(19)	$ (1)	(18)
Repurchase and retirement of common stock, shares		(62)
Ending Balance at May. 05, 2018	41,192	$ 150	107,171	(66,059)	(70)
Ending Balance, shares at May. 05, 2018		15,005
Beginning Balance at Feb. 02, 2019	27,151	$ 144	107,675	(80,594)	(74)
Beginning Balance, shares at Feb. 02, 2019		14,417
Adoption of ASC 842 - Leases | ASC 842	(2,576)			(2,576)
Net income	130			130
Dividends forfeited	1			1
Stock-based compensation	144	$ 1	143
Stock-based compensation, shares		75
Repurchase and retirement of common stock	(34)	$ (1)	(33)
Repurchase and retirement of common stock, shares		(116)
Ending Balance at May. 04, 2019	$ 24,816	$ 144	$ 107,785	$ (83,039)	$ (74)
Ending Balance, shares at May. 04, 2019		14,376

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Operating Activities
Net income	$ 130	$ 214
Adjustments to reconcile net income to net cash used in operating activities:
Depreciation and amortization	3,553	4,050
Stock-based compensation expense	144	328
Loss on impairment of long-lived assets	562	887
Loss on disposal of assets	188	13
Grow NJ award benefit	(643)	(707)
Amortization of deferred financing costs	177	165
Decrease (increase) in:
Trade receivables	(862)	(2,197)
Inventories	(1,261)	4,837
Prepaid expenses and other current assets	(448)	(252)
Operating leases and other non-current assets	6,317	(14)
Decrease in:
Accounts payable, accrued expenses, operating leases and other current liabilities	(4,931)	(9,031)
Operating leases and other non-current liabilities	(7,522)	(752)
Net cash used in operating activities	(4,596)	(2,459)
Investing Activities
Capital expenditures	(2,478)	(1,141)
Net cash used in investing activities	(2,478)	(1,141)
Financing Activities
Decrease in cash overdraft	1,106	(1,980)
Increase in line of credit borrowings	5,800	7,200
Proceeds from long-term debt	1,802
Repayment of long-term debt	(1,562)	(1,151)
Deferred financing costs paid		(80)
Withholding taxes on stock-based compensation paid in connection with repurchase of common stock	(33)	(19)
Net cash provided by financing activities	7,113	3,970
Net Increase in Cash and Cash Equivalents	39	370
Cash and Cash Equivalents, Beginning of Period	1,154	1,635
Cash and Cash Equivalents, End of Period	1,193	2,005
Supplemental Disclosures of Cash Flow Information:
Cash paid for interest	1,218	$ 968
Cash received for income taxes	$ (198)

XML

Basis of Financial Statement Presentation

3 Months Ended

May 04, 2019

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Financial Statement Presentation

1. BASIS OF FINANCIAL STATEMENT PRESENTATION

The accompanying unaudited consolidated financial statements for the three months ended May 4, 2019 and May 5, 2018 have been prepared in accordance with the requirements for Form 10-Q and Article 10 of Regulation S-X, and accordingly, certain information and footnote disclosures have been condensed or omitted. See the Company’s Annual Report on Form 10-K as of and for the year ended February 2, 2019 for Destination Maternity Corporation and subsidiaries (the “Company” or “Destination Maternity”) as filed with the Securities and Exchange Commission (“SEC”) for additional disclosures, including a summary of the Company’s accounting policies.

In the opinion of management, the consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary to present fairly the consolidated financial position, results of operations and cash flows of the Company for the periods presented. Since the Company’s operations are seasonal, the interim operating results of the Company may not be indicative of operating results for the full year. Certain prior year amounts have been reclassified to conform to current year presentation.

The Company operates on a 52/53-week fiscal year ending on the Saturday nearest January 31 of each year. References to the Company’s fiscal 2019 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 3, 2019 and will end February 1, 2020. References to the Company’s fiscal 2018 refer to the 52-week fiscal year, or periods within such fiscal year, which began February 4, 2018 and ended February 2, 2019.

XML

Earnings Per Share ("EPS")

3 Months Ended

May 04, 2019

Earnings Per Share [Abstract]

Earnings Per Share (“EPS”)

2. EARNINGS PER SHARE (“EPS”)  

Basic net income per share (“Basic EPS”) is computed by dividing net income by the weighted average number of common shares outstanding, excluding restricted stock awards for which the restrictions have not lapsed. Diluted net income per share (“Diluted EPS”) is computed by dividing net income by the weighted average number of common shares outstanding, after giving effect to the potential dilution, if applicable, from the assumed lapse of restrictions on restricted stock and restricted stock unit (“RSU”) awards, and from shares of common stock resulting from the assumed exercise of outstanding stock options. Common shares issuable in connection with the award of performance-based restricted stock units (“PRSUs”) are excluded from the calculation of EPS until the PRSUs’ performance conditions are achieved and the shares in respect of the PRSUs become issuable (see Note 14).

The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts):

	Three Months Ended
	May 4, 2019						May 5, 2018
	Net Income		Shares		EPS		Net Income		Shares		EPS
Basic EPS	$	130		13,825	$	0.01	$	214		13,839	$	0.02
Incremental shares from the assumed exercise of outstanding stock options		—		—		—		—		—		—
Incremental shares from the assumed lapse of restrictions on restricted stock and RSU awards		—		76		—		—		124		—
Diluted EPS	$	130		13,901	$	0.01	$	214		13,963	$	0.02

  Stock options and unvested restricted stock totaling 959,000 shares of the Company’s common stock were outstanding as of May 4, 2019, of which 610,000 shares were excluded from the calculation of Diluted EPS as the effect would have been antidilutive.   

XML

Trade Receivables

3 Months Ended

May 04, 2019

Receivables [Abstract]

Trade Receivables

3. TRADE RECEIVABLES

Trade receivables are recorded based on revenue recognized for sales of the Company’s merchandise and for other revenue earned by the Company through its marketing partnership programs and international franchise agreements, and are non-interest bearing. The Company evaluates the collectability of trade receivables based on a combination of factors, including aging of trade receivables, write-off experience, analysis of historical trends and expectations of future performance. An allowance for doubtful accounts is recorded for the amount of trade receivables that are considered unlikely to be collected. When the Company’s collection efforts are unsuccessful, uncollectible trade receivables are charged against the allowance for doubtful accounts. As of May 4, 2019 and February 2, 2019, the Company’s trade receivables were net of allowance for doubtful accounts of $166,000 and $166,000, respectively.

XML

Inventories

3 Months Ended

May 04, 2019

Inventory Disclosure [Abstract]

Inventories

4. INVENTORIES

Inventories were comprised of the following (in thousands):

	May 4, 2019		February 2, 2019
Finished goods	$	71,992	$	70,660
Work-in-progress		46		148
Raw materials		95		64
Total	$	72,133	$	70,872

XML

Accrued Expenses and Other Current Liabilities

3 Months Ended

May 04, 2019

Payables And Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

5. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities were comprised of the following (in thousands):

	May 4, 2019		February 2, 2019
Employee compensation and benefits	$	4,376	$	6,741
Insurance, primarily self-insurance reserves		3,125		3,049
Sales and use taxes		3,086		2,737
Accrued expenses		3,073		4,561
Gift certificates and store credits		2,915		3,464
Product return reserve		2,530		2,078
Deferred revenue		1,713		2,435
Audit and legal		1,463		1,341
Deferred rent		—		3,101
Other		2,327		1,549
Total	$	24,608	$	31,056

XML

Line of Credit

3 Months Ended

May 04, 2019

Debt Disclosure [Abstract]

Line of Credit

6. LINE OF CREDIT

After completion of a debt refinancing on February 1, 2018, the Company has in place a $50,000,000 senior secured revolving credit facility (the “Credit Facility”), which was entered into in conjunction with the issuance of the Company’s $25,000,000 Term Loan (as defined below) (see Note 7). Proceeds from advances under the Credit Facility, subject to certain restrictions, may be used to provide financing for working capital, letters of credit, capital expenditures, and other general corporate purposes.

The Credit Facility, which matures on January 31, 2023, contains various affirmative and negative covenants and representations and warranties, including the requirement that the Company maintain Excess Availability (as defined in the related Credit Agreement) of more than the greater of 10% of the Combined Loan Caps (as defined in the related Credit Agreement) and $7,000,000. In the event that the outstanding balance of the Term Loan exceeds the Term Loan Borrowing Base (as defined in the related Term Loan Agreement), then a reserve will be imposed against availability under the Credit Facility. The Credit Facility is secured by a security interest in the Company’s trade receivables, inventory, letter of credit rights, cash, intangibles and certain other assets. The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%. The Company also pays an unused line fee under the Credit Facility of 0.25% per annum.

Any amounts outstanding under the Credit Facility may be accelerated and become due and payable immediately and all loan and letter of credit commitments thereunder may be terminated upon an event of default and expiration of any applicable cure period. Events of default include: 1) nonpayment of obligations due under the subject loan agreement and related loan documents, 2) cross-defaults to other indebtedness and documents, 3) failure to perform any covenant or agreement contained in the subject loan agreement, 4) material misrepresentations, 5) failure to pay, or certain other defaults under, other material indebtedness of the Company, 6) certain bankruptcy or insolvency events, 7) a change of control, 8) indictments of the Company or senior management in a material forfeiture action, 9) default under certain material contracts to the extent such termination or default has or could reasonably be expected to have a material adverse effect, and 10) customary ERISA defaults, among others.

In connection with the original execution and subsequent amendments of the Credit Facility, the Company has incurred deferred financing costs of $1,281,000.  These deferred financing costs are being amortized over the term of the Credit Facility agreement and are included in “interest expense, net” in the consolidated statements of operations.

As of May 4, 2019, the Company had $26,200,000 in outstanding borrowings under the Credit Facility, $6,297,000 in letters of credit and $10,128,000 of availability based on the Company’s Borrowing Base formula and availability reserve requirements. As of May 5, 2018, the Company had $15,200,000 in outstanding borrowings under the Credit Facility, $7,327,000 in letters of credit and $20,223,000 of availability. For the three months ended May 4, 2019 and May 5, 2018 borrowings had a weighted interest rate of 4.53% and 3.60% per annum, respectively.During the three months ended May 4, 2019 and May 5, 2018 the Company’s average levels of direct borrowings were $27,509,000 and $19,436,000, respectively, and the Company’s maximum borrowings were $32,300,000 and $27,400,000, respectively.

XML

Long-Term Debt

3 Months Ended

May 04, 2019

Debt Disclosure [Abstract]

Long-Term Debt

7. LONG-TERM DEBT

On February 1, 2018 (the “Closing Date”), the Company has entered into a Term Loan Credit Agreement (the “Term Loan Agreement”) which provides for a term loan of up to $25,000,000 and matures on January 31, 2023 (the “Term Loan”).  On the Closing Date, the Company borrowed $22,500,000.   The Term Loan provided for an additional loan of $2,500,000, which could be borrowed at the Company’s discretion within a period of 45 days after delivery to the lender of the Company’s first quarter fiscal 2018 financial statements and satisfaction of certain other requirements. The Company met these requirements and borrowed the additional $2,500,000 on July 16, 2018.   

The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%. The Company is required to make minimum repayments of the principal amount of the Term Loan in quarterly installments of $312,500 which commenced on July 31, 2018, with the remaining outstanding balance payable on the maturity date. There is a minimum excess availability requirement of the greater of 10% of the Combined Loan Cap, as defined in the Term Loan Agreement, or $7,000,000. Additionally, the Term Loan can be prepaid at the Company’s option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of  a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount, if paid between the second and third anniversary of the Closing Date.

The Term Loan is secured by a security interest in substantially all of the assets of the Company, including accounts receivable, inventory, equipment, letter of credit rights, cash, intellectual property and other intangibles, and certain other assets. The security interest granted to the Term Lenders is, in certain respects, subordinate to the security interest granted to the Credit Facility Lender. The Term Loan Agreement prohibits the payment of dividends or share repurchases by the Company for three years and imposes certain restrictions on the Company’s ability to, among other things, incur additional indebtedness and enter into other various types of transactions.

        There were $2,455,000 of deferred financing costs incurred in connection with the Term Loan. These deferred financing costs are reflected as a direct deduction from the Term Loan liability in the consolidated balance sheets and are being amortized over the term of the Term Loan Agreement. The amortization is included in “interest expense, net” in the consolidated statements of operations.

As of May 4, 2019 and May 5, 2018, there was $23,750,000 and $22,500,000, respectively, of principal outstanding under the Term Loan.

On February 22, 2019, the Company entered into a 24-month, $1,802,000 software development financing arrangement. The note has monthly payments of $81,648 with an interest rate of 8.16%. As of May 4, 2019, there was $1,593,000 of principal outstanding.

As of May 4, 2019 and May 5, 2018, there was $2,149,000 and $5,284,000, respectively, outstanding under a five-year equipment financing arrangement with the Company’s Credit Facility bank. The equipment note bears annual interest at 3.38%, with payments of $272,000 (including interest) due monthly through December 2019. The equipment note is collateralized by substantially all of the material handling equipment at the Company’s distribution facility in Florence, New Jersey. Any amounts outstanding under the equipment note may be accelerated and become due and payable immediately upon an event of default and expiration of any applicable cure period. The specified events of default are substantially the same as those in the Credit Facility agreement (see Note 6).

On June 6, 2017, the Company received $3,401,000 in proceeds from a three-year financing arrangement in the form of a sale and leaseback for certain furniture, fixtures and software. Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36. At the end of the leaseback term, the Company has the option to extend the lease for an additional year or to repurchase the financed property for a price to be agreed upon. As of May 4, 2019, and May 5, 2018, there was $1,114,000 and $2,287,000 of principal outstanding under this financing arrangement.

XML

Leases

3 Months Ended

May 04, 2019

Lessee Disclosure [Abstract]

Leases

8. LEASES

The Company has entered into operating leases for all of its retail locations, distribution center and corporate office. Many of these leases include one or more renewal options which can extend the lease for up to an additional 15 years. In the event we are reasonably certain that an option to extend a lease will be exercised, we use the expected expiration date to determine the operating lease right-of-use asset and lease liability. We also have short-term leases that can be terminated by the Company or by the landlord with notification periods as short as 30 days, which are excluded from the operating lease liability. Some of our leases provide for rental payments based solely on a percent of retail sales which are treated as variable lease expenses and not included as part of the operating lease liability.  Most leases include payments for lease components such as minimum rent, non-lease components such as common area maintenance and not-lease components such as real estate taxes and insurance.  Finance leases were not material as of May 4, 2019 and the three-month period then ended.  

For the three months ended May 4, 2019, the components of lease expense were as follows (in thousands):

Fixed operating lease expense (1)	$	8,743
Variable operating lease expense		3,893
Total operating lease expense	$	12,636
(1) Includes short-term leases.

For the three months ended May 5, 2018, rent expense, including related occupancy costs such as insurance and maintenance paid to landlords, for non-cancellable operating leases amounted to $12.8 million.

The following table presents the operating lease balances within the Consolidated Balance Sheet, weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of May 4, 2019 ($ in thousands):

Lease Assets and Liabilities	Classification
Assets:
Operating lease ROU assets	Operating lease assets	$	128,065
Liabilities:
Current:
Operating lease liabilities	Operating lease liabilities	$	32,327
Long-term:
Operating lease liabilities	Operating lease and other non-current liabilities		119,636
Total undiscounted operating lease liabilities		$	151,963
Weighted average remaining lease term		6.4 years
Weighted average discount rate			7.40	%

The following table presents the maturity of the Company’s operating lease liabilities as of May 4, 2019 (in thousands):

Remainder of Fiscal 2019	$	32,864
2020		34,750
2021		28,555
2022		24,128
2023		20,969
Thereafter		53,693
Total operating lease payments		194,959
Less: Imputed interest		42,996
Total operating lease liabilities	$	151,963

The following table presents future minimum lease payments as previously disclosed in our 2018 Annual Report on Form 10-K  determined using the previous lease accounting standard.

2019	$	36,417
2020		29,682
2021		21,142
2022		21,698
2023		15,995
Thereafter		48,462
Total operating lease liabilities	$	173,396

Supplemental cash flow information related to the Company’s operating leases for the three months ended May 4, 2019 (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities	$	11,994
ROU assets obtained in exchange for operating lease liability		1,829

XML

Fair Value Measurements

3 Months Ended

May 04, 2019

Fair Value Disclosures [Abstract]

Fair Value Measurements

9. FAIR VALUE MEASUREMENTS

The accounting standard for fair value measurements defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The standard establishes a framework for measuring fair value focused on exit price and creates a fair value hierarchy in order to increase the consistency and comparability of fair value measurements as follows:

• Level 1 – Quoted market prices in active markets for identical assets or liabilities

• Level 2 – Observable market-based inputs or inputs that are corroborated by observable market data

• Level 3 – Unobservable inputs that are not corroborated by market data

At both May 4, 2019 and February 2, 2019, the Company had cash equivalents of $4,000. The Company’s cash equivalents consist of investments in money market funds for which the carrying value approximates fair value (based on Level 1 inputs) due to the short-term nature of those instruments. The carrying values of trade receivables and accounts payable approximate fair value due to the short-term nature of those instruments.

The Company’s Credit Facility has variable interest rates that are tied to market indices. As of May 4, 2019 and February 2, 2019, the Company had $26,200,000 and $20,400,000 respectively, of direct borrowings outstanding under the Credit Facility. The carrying value of the Company’s Credit Facility borrowings approximates fair value as the variable interest rates approximate current market rates, which the Company considers to be Level 2 inputs.

The Company’s Term Loan, which represents a significant majority of the Company’s long-term debt, bears interest at variable rates, which adjust based on market conditions with a minimum annual rate of 9.00%. The carrying value of the Company’s Term Loan approximates fair value as the variable interest rates approximate current market rates for similar instruments available to companies with comparable credit quality, which the Company considers to be Level 2 inputs. The fair value of the Company’s fixed-rate equipment notes were determined using a discounted cash flow analysis based on interest rates currently available to the Company, which the Company considers to be Level 2 inputs. The difference between the carrying value and fair value of long-term debt held by the Company with a fixed rate of interest is not material.

XML

Net Sales

3 Months Ended

May 04, 2019

Revenues [Abstract]

Net Sales

10. NET SALES

The following disaggregates the Company’s net sales by major source (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Retail stores	$	56,464	$	62,987
Leased departments		9,348		9,989
Total retail locations		65,812		72,976
E-commerce		22,672		25,482
Marketing partnerships		4,580		3,935
Wholesale and franchise		1,150		834
Total net sales	$	94,213	$	103,227

XML

Other Charges

3 Months Ended

May 04, 2019

Other Charges Related To Management And Organizational Changes And Proxy Solicitation [Abstract]

Other Charges

11. OTHER CHARGES

Over the last several years the Company has engaged in a series of management and organizational changes and, in connection therewith, retained consulting firms to review its costs and business strategy associated with such management and organizational changes.  The Company’s Board of Directors authorized changes to the Company’s chief executive function, including, most recently, the May 23, 2018 appointment of Marla Ryan as Chief Executive Officer, who replaced Melissa Payner-Gregor who had served as interim Chief Executive Officer since January 2, 2018. Ronald Masciantonio, the Company’s Chief Administrative Officer, resigned from his position on June 4, 2018.  David Stern, the Company’s former Chief Financial Officer, departed the Company effective at the close of business on August 10, 2018. On January 19, 2019, Dave J. Helkey was appointed Chief Operating Officer and Chief Financial Officer. The Company also paid one-time retention bonuses with service conditions to certain key management personnel which are being recorded over the service period, while reducing its overall headcount to create a more efficient and effective operating structure. During the three months ended May 4, 2019 and May 5, 2018, the Company incurred $662,000 and $264,000, respectively, of charges related to these management and organizational changes.

In the first quarter of fiscal 2018, the Company received notification from a stockholder group of their intent to nominate a slate of alternative nominees for election to the Company’s Board of Directors at the Annual Meeting of Stockholders that was held on May 23, 2018 (the “Proxy Solicitation”).  At the 2018 Annual Meeting of Stockholders the Company’s stockholders replaced the incumbent board in its entirety and elected Holly N. Alden, Christopher B. Morgan, Marla A Ryan and Anne-Charlotte Windal as the Company’s new Board of Directors. During the three months ended May 5, 2018, the Company incurred $886,000 of charges related to the Proxy Solicitation. 

A summary of charges incurred in connection with management and organizational changes and the proxy solicitation is as follows (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Management and organizational changes	$	662	$	264
Proxy solicitation		—		886
Total other charges	$	662	$	1,150

XML

Government Incentives

3 Months Ended

May 04, 2019

Government Incentives Disclosure [Abstract]

Government Incentives

12. GOVERNMENT INCENTIVES

In fiscal 2015, the Company completed the relocation of its corporate headquarters and distribution operations from Philadelphia, Pennsylvania to southern New Jersey. To partially offset the costs of these relocations, the Board of the New Jersey Economic Development Authority (“NJEDA”) approved the Company for an incentive package of up to $40,000,000 in benefits under the Grow New Jersey Assistance Program (“Grow NJ”) in the form of transferrable income tax credits over a ten-year period from the State of New Jersey. The award provides annually over a ten-year period up to $7,000 per eligible new full-time job, as defined under Grow NJ, with a requirement that at least 100 eligible jobs be created and subject to an annual award limit of $4,000,000.

The Grow NJ award requires an annual compliance report that includes certification of average annual employment figures after the end of each fiscal year. After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period. The Company believes the likelihood of any recapture and repayment is remote.

The annual benefit from the Grow NJ award available to the Company is expected to significantly exceed the Company’s annual income tax liability to the State of New Jersey. In order to maximize the realizable value of the incentive package, the Company entered into an agreement with a third party to sell up to 100% of the annual income tax credits awarded to the Company. The Company recognizes its Grow NJ award on an annual basis for each fiscal year based on the realizable value of the award earned and expected to be received, primarily from the sale of the income tax credits, net of any associated costs. The Grow NJ award is reflected in the Company’s consolidated financial statements as a reduction to the costs incurred by the Company in connection with the relocations. The expected realizable amount of the Grow NJ award is included in the consolidated balance sheet in deferred income taxes. As of May 4, 2019, the Company had recorded a deferred tax asset of $3,314,000 related to the NJ Grow award. Of this amount, $2,671,000 relates to the annual award earned in fiscal 2018, the cash proceeds of which are expected to be received during fiscal 2019. In December 2018, the Company received $2,829,000 cash proceeds, net of costs, from the receipt and subsequent sale of the  tax credit certificate earned for fiscal 2017. During the three months ended May 4, 2019, the Company recognized a cost reduction related to the Grow NJ award in the amount of $617,000,as compared to the three months ended May 5, 2018 in which the Company recognized $710,000.  

XML

Income Taxes

3 Months Ended

May 04, 2019

Income Tax Disclosure [Abstract]

Income Taxes

13. INCOME TAXES

 Accounting Standards Codification (“ASC”) Topic 740, Income Taxes, requires that a valuation allowance be recorded to reduce deferred tax assets when it is more likely than not that the tax benefit of the deferred tax assets will not be realized. In situations where a three-year cumulative loss condition exists, accounting standards limit the ability to consider projections of future results as positive evidence to assess the realizability of deferred tax assets.  In fiscal 2016 the Company’s financial results reflected a three-year cumulative loss and consequently, in fiscal 2016 the Company recorded a non-cash charge as a valuation allowance against substantially all of its deferred tax assets.  Three-year cumulative losses have continued since fiscal 2016, and the Company continues to record a valuation allowance against its deferred tax assets.

XML

Equity Award Plans

3 Months Ended

May 04, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Equity Award Plans

14. EQUITY AWARD PLANS

In January 2006, the stockholders of the Company approved the adoption of the Amended and Restated 2005 Equity Incentive Plan (the “2005 Plan”) and, subsequently, have approved amendments to increase the number of issuable shares under the 2005 Plan. Under the 2005 Plan, employees, directors, consultants and other individuals who provide services to the Company may be granted awards in the form of stock options, stock appreciation rights, restricted stock, RSUs or deferred stock units. Up to 3,550,000 shares of the Company’s common stock may be issued in respect of awards under the 2005 Plan, as amended, with no more than 2,250,000 of those shares permitted to be issued in respect of restricted stock, RSUs, or deferred stock units granted under the 2005 Plan. Awards of stock options to purchase the Company’s common stock will have exercise prices as determined by the Compensation Committee of the Board of Directors but such exercise prices may not be lower than the fair market value of the stock on the date of grant.

No stock options have been granted by the Company with an exercise price less than the fair market value of the Company’s common stock on the date of grant for any of the periods presented. The majority of the stock options issued under the 2005 Plan vest ratably over four-year periods and generally expire ten years from the date of grant, and restricted stock and time-based RSU awards issued under the 2005 Plan generally have restrictions that lapse ratably over periods ranging from one to four years however, awards with respect to up to 177,500 shares of our common stock may be granted under the 2005 Plan with a vesting period of less than one year. Performance-based awards issued under the 2005 Plan generally vest based upon the achievement of pre-established performance goals over a specified three-year period. The number of shares of our common stock that may be earned in respect of performance-based awards may be greater or less than the target number of shares granted based on the actual performance achieved. The non-executive chairman of the Company’s Board of Directors is granted 6,000 shares of restricted stock on an annual basis and each non-employee director, other than the non-executive chairman, and Christopher B. Morgan, of the Company’s Board of Directors is eligible for a grant of 4,000 shares of restricted stock on an annual basis, in each case that will generally vest one year from the date of grant. The Company issues new shares of common stock upon exercise of vested stock options. As of May 4, 2019, there were 834,231 shares of the Company’s common stock available for grants of awards under the 2005 Plan.  

Stock option activity for all plans was as follows:

	Outstanding Stock Options (in thousands)			Weighted Average Exercise Price		Weighted Average Remaining Life		Aggregate Intrinsic Value (in thousands)
Balance as of February 2, 2019	439			$	6.06
Granted	45			2.33
Exercised		—			—
Forfeited		(41	)	4.17
Expired		—			—
Balance as of May 4, 2019		443		$	5.85	8.3			—
Exercisable as of May 4, 2019	161			$	9.75		6.7		—

The following table summarizes information about stock options outstanding as of May 4, 2019:

	Stock Options Outstanding					Stock Options Exercisable
Range of Exercise Prices	Number Outstanding (in thousands)	Weighted Average Remaining Life		Weighted Average Exercise Price		Number Exercisable (in thousands)		Weighted Average Exercise Price
$ 2.33 to $  5.00	237		9.2	$	2.63		43	$	2.65
5.01 to   10.00	134		8.3		6.32	48			7.49
10.01 to   31.38	72		5.2		15.53	70			15.69
$ 2.33 to $31.38	443		8.3	$	5.85		161	$	9.75

The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes grants of 113,326 PRSUs which is the number of shares of common stock that would be delivered upon vesting assuming that the target level of performance is achieved.  If performance was achieved at the maximum level, 226,652 shares of common stock would be delivered in respect of such PRSU’s.  

	Outstanding Restricted Shares (in thousands)			Weighted Average Grant Date Fair Value
Unvested as of February 2, 2019		606		$	3.34
Granted		75			2.45
Vested		(64	)		2.72
Forfeited		(100	)		2.68
Unvested as of May 4, 2019		517		$	3.26

XML

Recent Accounting Pronouncements

3 Months Ended

May 04, 2019

New Accounting Pronouncements And Changes In Accounting Principles [Abstract]

Recent Accounting Pronouncements

15. RECENT ACCOUNTING PRONOUNCEMENTS

Adopted

  In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to hereafter as ASC 842. ASC 842 affects any entity that enters into a lease, as that term is defined, and its guidance supersedes Topic 840, Leases. As it substantively relates to the Company, ASC 842 requires lessees to recognize a right-of-use asset (“ROU asset”) and a lease liability, initially measured at the present value of the lease payments, in the consolidated balance sheet.

On February 3, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements in effect at the beginning of the period of adoption. Results for periods beginning February 3, 2019 are presented under ASC 842, and prior period amounts were not restated and continue to be reported under the Company’s historical method of lease accounting, ASC 840, Leases. Adoption of ASC 842 had a material impact of the Company’s balance sheet as the result of recognizing ROU assets and lease liabilities for operating leases. There was no material impact to our consolidated statement of operations or cash flows and there was no impact to covenant compliance under our current debt agreements. Accounting for finance leases remained substantially unchanged. For leases that commenced prior to the effective date of ASC 842 the Company adopted practical expedients that allowed for retention of its previous assessment of the following: (i) whether a contract contained a lease, (ii) lease classification and (iii) initial direct costs. The Company also elected not to recognize ROU assets and lease liabilities for leases with a term of 12 months or less and to account for leases which have both lease and non-lease components as a single component.

At the date of adoption, the Company recorded operating lease ROU assets of $135 million, operating lease liabilities of $159 million, primarily related to its retail real estate, distribution center and corporate office and a $2.6 million adjustment to accumulated deficit resulting from the impairment of certain operating lease ROU assets. Refer to Note 8. Leases for additional disclosures required by ASC 842.

The Company determines if an arrangement is a lease at inception. ROU assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement of the lease based on the net present value of the fixed lease payments over the lease term.  The lease term includes options to extend or terminate the lease when it is reasonably certain that we will exercise the option. ROU assets include prepaid lease payments, lease incentives received and capitalized lease costs. As the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on information available at the lease commencement date to determine the present value of lease payments. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense, while the expense for finance leases is recognized as depreciation and interest expense over the lease term.  

In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred over the non-cancellable term of the cloud computing arrangements plus any optional renewal periods (1) that are reasonably certain to be exercised by the customer or (2) for which exercise of the renewal option is controlled by the cloud service provider. The effective date of this pronouncement is for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and early adoption is permitted. The Company adopted ASU 2018-15 effective February 3, 2019, and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

XML

Commitments and Contingencies

3 Months Ended

May 04, 2019

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

16. COMMITMENTS AND CONTINGENCIES

From time to time, the Company is named as a defendant in legal actions arising from normal business activities. Litigation is inherently unpredictable, and although the amount of any liability that could arise with respect to currently pending actions cannot be accurately predicted, the Company does not believe that the resolution of any pending action will have a material adverse effect on its financial position, results of operations or liquidity.

The Company has recently gained access to inspect inventory subject to a potential loss that occurred while the inventory was in transit to the Company’s distribution center. While still in the process of evaluating the inventory, the Company believes that it has insurance coverage in place to cover any potential loss, should such a loss occur.

XML

Segment and Enterprise Wide Disclosures

3 Months Ended

May 04, 2019

Segment Reporting [Abstract]

Segment and Enterprise Wide Disclosures

17. SEGMENT AND ENTERPRISE WIDE DISCLOSURES

Operating Segment. For purposes of the disclosure requirements for segments of a business enterprise, the Company has determined that its business is comprised of one operating segment: the design, manufacture and sale of maternity apparel and related accessories. While the Company offers a wide range of products for sale, the substantial portion of its products are initially distributed through the same distribution facilities, many of the Company’s products are manufactured at common contract manufacturer production facilities, the Company’s products are marketed through a common marketing department, and these products are sold to a similar customer base consisting of expectant mothers.

Geographic Information. Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Net Sales
United States	$	90,646	$	98,250
Foreign		3,567		4,977

	May 4, 2019		February 2, 2019
Long-Lived Assets
United States	$	49,995	$	51,068
Foreign		1,078		1,228

Major Customers. For the periods presented, the Company did not have any one customer who represented more than 10% of its net sales.

XML

Interest Expense, Net

3 Months Ended

May 04, 2019

Banking And Thrift Interest [Abstract]

Interest Expense, Net

18. INTEREST EXPENSE, NET

Interest expense, net was comprised of the following (in thousands):

	Three Months Ended
	May 4, 2019			May 5, 2018
Interest expense	$	1,416		$	1,158
Interest income		(1	)		(1	)
Interest expense, net	$	1,415		$	1,157

XML

Recent Accounting Pronouncements (Policies)

3 Months Ended

May 04, 2019

Accounting Policies [Abstract]

Adopted

Adopted

  In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842), referred to hereafter as ASC 842. ASC 842 affects any entity that enters into a lease, as that term is defined, and its guidance supersedes Topic 840, Leases. As it substantively relates to the Company, ASC 842 requires lessees to recognize a right-of-use asset (“ROU asset”) and a lease liability, initially measured at the present value of the lease payments, in the consolidated balance sheet.

On February 3, 2019, the Company adopted ASC 842 using the modified retrospective method for all lease arrangements in effect at the beginning of the period of adoption. Results for periods beginning February 3, 2019 are presented under ASC 842, and prior period amounts were not restated and continue to be reported under the Company’s historical method of lease accounting, ASC 840, Leases. Adoption of ASC 842 had a material impact of the Company’s balance sheet as the result of recognizing ROU assets and lease liabilities for operating leases. There was no material impact to our consolidated statement of operations or cash flows and there was no impact to covenant compliance under our current debt agreements. Accounting for finance leases remained substantially unchanged. For leases that commenced prior to the effective date of ASC 842 the Company adopted practical expedients that allowed for retention of its previous assessment of the following: (i) whether a contract contained a lease, (ii) lease classification and (iii) initial direct costs. The Company also elected not to recognize ROU assets and lease liabilities for leases with a term of 12 months or less and to account for leases which have both lease and non-lease components as a single component.

At the date of adoption, the Company recorded operating lease ROU assets of $135 million, operating lease liabilities of $159 million, primarily related to its retail real estate, distribution center and corporate office and a $2.6 million adjustment to accumulated deficit resulting from the impairment of certain operating lease ROU assets. Refer to Note 8. Leases for additional disclosures required by ASC 842.

The Company determines if an arrangement is a lease at inception. ROU assets represent the Company’s right to use an underlying asset during the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement of the lease based on the net present value of the fixed lease payments over the lease term.  The lease term includes options to extend or terminate the lease when it is reasonably certain that we will exercise the option. ROU assets include prepaid lease payments, lease incentives received and capitalized lease costs. As the Company’s leases do not provide an implicit interest rate, the Company uses its incremental borrowing rate based on information available at the lease commencement date to determine the present value of lease payments. Lease expense for operating leases is recognized on a straight-line basis over the lease term as an operating expense, while the expense for finance leases is recognized as depreciation and interest expense over the lease term.  

In August 2018, the FASB issued ASU 2018-15, Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement that is a Service Contract. ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred over the non-cancellable term of the cloud computing arrangements plus any optional renewal periods (1) that are reasonably certain to be exercised by the customer or (2) for which exercise of the renewal option is controlled by the cloud service provider. The effective date of this pronouncement is for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years, and early adoption is permitted. The Company adopted ASU 2018-15 effective February 3, 2019, and the adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows.

XML

Earnings Per Share ("EPS") (Tables)

3 Months Ended

May 04, 2019

Earnings Per Share [Abstract]

Summary of Basic EPS and Diluted EPS Calculations

The following tables summarize the Basic EPS and Diluted EPS calculations (in thousands, except per share amounts):

	Three Months Ended
	May 4, 2019						May 5, 2018
	Net Income		Shares		EPS		Net Income		Shares		EPS
Basic EPS	$	130		13,825	$	0.01	$	214		13,839	$	0.02
Incremental shares from the assumed exercise of outstanding stock options		—		—		—		—		—		—
Incremental shares from the assumed lapse of restrictions on restricted stock and RSU awards		—		76		—		—		124		—
Diluted EPS	$	130		13,901	$	0.01	$	214		13,963	$	0.02

XML

Inventories (Tables)

3 Months Ended

May 04, 2019

Inventory Disclosure [Abstract]

Inventories

Inventories were comprised of the following (in thousands):

	May 4, 2019		February 2, 2019
Finished goods	$	71,992	$	70,660
Work-in-progress		46		148
Raw materials		95		64
Total	$	72,133	$	70,872

XML

Accrued Expenses and Other Current Liabilities (Tables)

3 Months Ended

May 04, 2019

Payables And Accruals [Abstract]

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities were comprised of the following (in thousands):

	May 4, 2019		February 2, 2019
Employee compensation and benefits	$	4,376	$	6,741
Insurance, primarily self-insurance reserves		3,125		3,049
Sales and use taxes		3,086		2,737
Accrued expenses		3,073		4,561
Gift certificates and store credits		2,915		3,464
Product return reserve		2,530		2,078
Deferred revenue		1,713		2,435
Audit and legal		1,463		1,341
Deferred rent		—		3,101
Other		2,327		1,549
Total	$	24,608	$	31,056

XML

Leases (Tables)

3 Months Ended

May 04, 2019

Lessee Disclosure [Abstract]

Schedule of Components of Lease Expense

For the three months ended May 4, 2019, the components of lease expense were as follows (in thousands):

Fixed operating lease expense (1)	$	8,743
Variable operating lease expense		3,893
Total operating lease expense	$	12,636
(1) Includes short-term leases.

Schedule of Operating Lease Balances within Consolidated Balance Sheet, Weighted Average Remaining Lease Term and Weighted Average Discount Rates

The following table presents the operating lease balances within the Consolidated Balance Sheet, weighted average remaining lease term and weighted average discount rates related to the Company’s operating leases as of May 4, 2019 ($ in thousands):

Lease Assets and Liabilities	Classification
Assets:
Operating lease ROU assets	Operating lease assets	$	128,065
Liabilities:
Current:
Operating lease liabilities	Operating lease liabilities	$	32,327
Long-term:
Operating lease liabilities	Operating lease and other non-current liabilities		119,636
Total undiscounted operating lease liabilities		$	151,963
Weighted average remaining lease term		6.4 years
Weighted average discount rate			7.40	%

Schedule of Maturity of Operating Lease Liabilities

The following table presents the maturity of the Company’s operating lease liabilities as of May 4, 2019 (in thousands):

Remainder of Fiscal 2019	$	32,864
2020		34,750
2021		28,555
2022		24,128
2023		20,969
Thereafter		53,693
Total operating lease payments		194,959
Less: Imputed interest		42,996
Total operating lease liabilities	$	151,963

Future Annual Minimum Operating Lease Payments

The following table presents future minimum lease payments as previously disclosed in our 2018 Annual Report on Form 10-K  determined using the previous lease accounting standard.

2019	$	36,417
2020		29,682
2021		21,142
2022		21,698
2023		15,995
Thereafter		48,462
Total operating lease liabilities	$	173,396

Schedule of Supplemental Cash Flow Information Related to Operating Leases

Supplemental cash flow information related to the Company’s operating leases for the three months ended May 4, 2019 (in thousands):

Cash paid for amounts included in the measurement of operating lease liabilities	$	11,994
ROU assets obtained in exchange for operating lease liability		1,829

XML

Net Sales (Tables)

3 Months Ended

May 04, 2019

Revenues [Abstract]

Schedule of Disaggregation of Company's Net Sales by Major Source

The following disaggregates the Company’s net sales by major source (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Retail stores	$	56,464	$	62,987
Leased departments		9,348		9,989
Total retail locations		65,812		72,976
E-commerce		22,672		25,482
Marketing partnerships		4,580		3,935
Wholesale and franchise		1,150		834
Total net sales	$	94,213	$	103,227

XML

Other Charges (Tables)

3 Months Ended

May 04, 2019

Other Charges Related To Management And Organizational Changes And Proxy Solicitation [Abstract]

Summary of Charges Incurred in Management and Organizational Changes and Proxy Solicitation

A summary of charges incurred in connection with management and organizational changes and the proxy solicitation is as follows (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Management and organizational changes	$	662	$	264
Proxy solicitation		—		886
Total other charges	$	662	$	1,150

XML

Equity Award Plans (Tables)

3 Months Ended

May 04, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Option Activity for All Plans

Stock option activity for all plans was as follows:

	Outstanding Stock Options (in thousands)			Weighted Average Exercise Price		Weighted Average Remaining Life		Aggregate Intrinsic Value (in thousands)
Balance as of February 2, 2019	439			$	6.06
Granted	45			2.33
Exercised		—			—
Forfeited		(41	)	4.17
Expired		—			—
Balance as of May 4, 2019		443		$	5.85	8.3			—
Exercisable as of May 4, 2019	161			$	9.75		6.7		—

Summarizes Information about Stock Options Outstanding

The following table summarizes information about stock options outstanding as of May 4, 2019:

	Stock Options Outstanding					Stock Options Exercisable
Range of Exercise Prices	Number Outstanding (in thousands)	Weighted Average Remaining Life		Weighted Average Exercise Price		Number Exercisable (in thousands)		Weighted Average Exercise Price
$ 2.33 to $  5.00	237		9.2	$	2.63		43	$	2.65
5.01 to   10.00	134		8.3		6.32	48			7.49
10.01 to   31.38	72		5.2		15.53	70			15.69
$ 2.33 to $31.38	443		8.3	$	5.85		161	$	9.75

Restricted Stock Activity

The following table summarizes information about restricted stock and RSU activity for the 2005 Plan and includes grants of 113,326 PRSUs which is the number of shares of common stock that would be delivered upon vesting assuming that the target level of performance is achieved.  If performance was achieved at the maximum level, 226,652 shares of common stock would be delivered in respect of such PRSU’s.  

	Outstanding Restricted Shares (in thousands)			Weighted Average Grant Date Fair Value
Unvested as of February 2, 2019		606		$	3.34
Granted		75			2.45
Vested		(64	)		2.72
Forfeited		(100	)		2.68
Unvested as of May 4, 2019		517		$	3.26

XML

Segment and Enterprise Wide Disclosures (Tables)

3 Months Ended

May 04, 2019

Segment Reporting [Abstract]

Operations by Geographic Area

Geographic Information. Geographic revenue information is allocated based on the country in which the products or services are sold, and in the case of international franchise revenues, on the location of the customer. Information concerning the Company’s operations by geographic area was as follows (in thousands):

	Three Months Ended
	May 4, 2019		May 5, 2018
Net Sales
United States	$	90,646	$	98,250
Foreign		3,567		4,977

	May 4, 2019		February 2, 2019
Long-Lived Assets
United States	$	49,995	$	51,068
Foreign		1,078		1,228

XML

Interest Expense, Net (Tables)

3 Months Ended

May 04, 2019

Banking And Thrift Interest [Abstract]

Interest Expense, Net

Interest expense, net was comprised of the following (in thousands):

	Three Months Ended
	May 4, 2019			May 5, 2018
Interest expense	$	1,416		$	1,158
Interest income		(1	)		(1	)
Interest expense, net	$	1,415		$	1,157

XML

Earnings Per Share ("EPS") and Dividends - Summary of Basic EPS and Diluted EPS Calculations (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Earnings Per Share Diluted [Line Items]
Net Income	$ 130	$ 214
Average shares outstanding— Basic	13,825	13,839
Diluted shares	13,901	13,963
Basic EPS	$ 0.01	$ 0.02
Diluted EPS	$ 0.01	$ 0.02
Restricted Stock
Earnings Per Share Diluted [Line Items]
Incremental shares from the assumed lapse of restrictions on restricted stock and RSU awards	76	124

XML

Earnings Per Share ("EPS") - Additional Information (Details)	3 Months Ended
	May 04, 2019 shares
Earnings Per Share Diluted [Line Items]
Options and unvested restricted stock	610,000
Common Stock
Earnings Per Share Diluted [Line Items]
Stock options and unvested restricted stock	959,000

XML

Trade Receivables - Additional Information (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Receivables [Abstract]
Trade receivables, allowance for doubtful accounts	$ 166	$ 166

XML

Inventories - Inventories (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Inventory Disclosure [Abstract]
Finished goods	$ 71,992	$ 70,660
Work-in-progress	46	148
Raw materials	95	64
Total	$ 72,133	$ 70,872

XML

Accrued Expenses and Other Current Liabilities - Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019
Payables and Accruals [Abstract]
Employee compensation and benefits	$ 4,376	$ 6,741
Insurance, primarily self-insurance reserves	3,125	3,049
Sales and use taxes	3,086	2,737
Accrued expenses	3,073	4,561
Gift certificates and store credits	2,915	3,464
Product return reserve	2,530	2,078
Deferred revenue	1,713	2,435
Audit and legal	1,463	1,341
Deferred rent		3,101
Other	2,327	1,549
Total	$ 24,608	$ 31,056

XML

Line of Credit - Additional Information (Details) - USD ($)		3 Months Ended
	Feb. 01, 2018	May 04, 2019	May 05, 2018	Feb. 02, 2019
Line Of Credit Facility [Line Items]
Minimum excess availability on Combined Loan Cap	10.00%	10.00%
Minimum amount excess availability on Combined Loan Cap	$ 7,000,000,000	$ 7,000,000
Payment of financing costs			$ 80,000
Outstanding borrowings under Credit Facility		26,200,000	15,200,000	$ 20,400,000
Letters of credit		6,297,000	7,327,000
Line of credit availability		$ 10,128,000	$ 20,223,000
Borrowings interest rate		4.53%	3.60%
Line of credit, outstanding borrowings		$ 27,509,000	$ 19,436,000
Line of credit borrowings during period		$ 32,300,000	$ 27,400,000
Senior Secured Revolving Credit Facility
Line Of Credit Facility [Line Items]
Credit facility, maximum borrowing capacity	50,000,000
Line of credit expiration date		Jan. 31, 2023
Unused line fee under the Credit Facility		0.25%
Credit Facility Description of Variable Rate Basis		The interest rate on outstanding borrowings is equal to, at the Company’s election, either 1) the lender’s base rate plus 0.50% or 2) a LIBOR rate plus 1.0%.
Deferred financing costs		$ 1,281,000
Senior Secured Revolving Credit Facility | Base Rate
Line Of Credit Facility [Line Items]
Applicable margin rate		0.50%
Senior Secured Revolving Credit Facility | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Applicable margin rate		1.00%
Term Loan
Line Of Credit Facility [Line Items]
Loan available for borrowing	$ 25,000,000
Line of credit expiration date	Jan. 31, 2023
Credit Facility Description of Variable Rate Basis		The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.
Term Loan | London Interbank Offered Rate (LIBOR)
Line Of Credit Facility [Line Items]
Applicable margin rate	9.00%

XML

Long-Term Debt - Additional Information (Details) - USD ($)				3 Months Ended	4 Months Ended
	Feb. 22, 2019	Feb. 01, 2018	Jun. 06, 2017	May 04, 2019	Jan. 31, 2015	Jul. 16, 2018	May 05, 2018
Debt Instrument [Line Items]
Minimum excess availability on Combined Loan Cap		10.00%		10.00%
Minimum amount excess availability on Combined Loan Cap		$ 7,000,000,000		$ 7,000,000
Principal outstanding				1,593,000
Sale and leaseback transaction, financing agreement period	24 months		3 years
Principal outstanding	$ 1,802,000			$ 1,114,000			$ 2,287,000
Monthly payments for first 24 months	$ 82,000		$ 123,000
Percentage of interest on equipment financing arrangement	8.16%
Sale and leaseback, transaction date				June 6, 2017
Sale and leaseback, description of assets				certain furniture, fixtures and software
Monthly payments under leaseback arrangement for 25 to 36 months			48,000
Sale and leaseback, payment terms				Monthly payments under the leaseback arrangement are $123,000 for the first 24 months and $48,000 for months 25 to 36.
Equipment Loan
Debt Instrument [Line Items]
Percentage of interest on equipment financing arrangement					3.38%
Principal outstanding under equipment note				$ 2,149,000			5,284,000
Equipment financing arrangement period				5 years
Monthly payments for equipment financing arrangement					$ 272,000
Debt instrument maturity date					Dec. 31, 2019
Term Loan
Debt Instrument [Line Items]
Loan available for borrowing		$ 25,000,000
Line of credit maturity date		Jan. 31, 2023
Long-term debt borrowed		$ 22,500,000
Additional loan available for borrowing		$ 2,500,000
Period of delivery to the lender		45 days
Additional loan amount borrowed						$ 2,500,000
Credit Facility Description of Variable Rate Basis				The interest rate on the Term Loan is equal to a LIBOR rate plus 9.0%.
Debt Instrument, frequency of periodic payment				Quarterly
Debt instrument, payment terms				The Term Loan can be prepaid at the Company's option subject to certain restrictions and subject to a prepayment premium as follows: 1) if the prepayment occurs on or prior to the second anniversary of the Closing Date, the greater of a) interest on the prepayment that would otherwise have been paid with the 24 month period following the Closing Date minus actual interest payments made through the prepayment date and b) 2% of the prepayment and 2) 2% of the prepayment amount if paid between the second and third anniversary of the Closing Date.
Debt Instrument, frequency of periodic payment, commencing date				Jul. 31, 2018
Dividends payment or share repurchases prohibition period				3 years
Deferred financing costs				$ 2,455,000
Principal outstanding				$ 23,750,000			$ 22,500,000
Proceeds from equipment financing transaction			$ 3,401,000
Term Loan | London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Applicable margin rate		9.00%
Term Loan | Minimum
Debt Instrument [Line Items]
Debt instruments, periodic payments, principal		$ 312,500
Term Loan | Maximum
Debt Instrument [Line Items]
Loan available for borrowing		$ 25,000,000

XML

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	May 04, 2019	May 05, 2018
Lessee Lease Description [Line Items]
Description of option to extend, operating lease	Many of these leases include one or more renewal options which can extend the lease for up to an additional 15 years.
Operating lease, existence of option to extend	true
Description of option to terminate, operating lease	We also have short-term leases that can be terminated by the Company or by the landlord with notification periods as short as 30 days
Operating lease, existence of option to terminate	true
Operating lease, notice period required for termination	30 days
Rent expense		$ 12.8
Maximum
Lessee Lease Description [Line Items]
Operating lease, renewal term	15 years

XML

Leases - Schedule of Components of Lease Expense (Details) $ in Thousands	3 Months Ended
	May 04, 2019 USD ($)
Lessee Disclosure [Abstract]
Fixed operating lease expense	$ 8,743
Variable operating lease expense	3,893
Total operating lease expense	$ 12,636

XML

Leases - Schedule of Operating Lease Balances within Consolidated Balance Sheet, Weighted Average Remaining Lease Term and Weighted Average Discount Rates (Details) $ in Thousands	May 04, 2019 USD ($)
Assets:
Operating lease ROU assets	$ 128,065
Current:
Operating lease liabilities	32,327
Long-term:
Operating lease liabilities	$ 119,636
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	dest:OperatingLeaseAndOtherNonCurrentLiabilities
Total undiscounted operating lease liabilities	$ 151,963
Weighted average remaining lease term	6 years 4 months 24 days
Weighted average discount rate	7.40%

XML

Leases - Schedule of Maturity of Operating Lease Liabilities (Details) $ in Thousands	May 04, 2019 USD ($)
Operating Lease Liabilities Payments Due [Abstract]
Remainder of Fiscal 2019	$ 32,864
2020	34,750
2021	28,555
2022	24,128
2023	20,969
Thereafter	53,693
Total operating lease payments	194,959
Less: Imputed interest	42,996
Total operating lease liabilities	$ 151,963

XML

Leases - Future Annual Minimum Operating Lease Payments (Details) $ in Thousands	Feb. 02, 2019 USD ($)
Operating Leases Future Minimum Payments Due [Abstract]
2019	$ 36,417
2020	29,682
2021	21,142
2022	21,698
2023	15,995
Thereafter	48,462
Total operating lease liabilities	$ 173,396

XML

Leases - Schedule of Supplemental Cash Flow Information Related to Operating Leases (Details) $ in Thousands	3 Months Ended
	May 04, 2019 USD ($)
Lessee Disclosure [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 11,994
ROU assets obtained in exchange for operating lease liability	$ 1,829

XML

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 02, 2019	May 05, 2018
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Cash equivalents held by the Company	$ 4	$ 4
Outstanding borrowings under Credit Facility	$ 26,200	$ 20,400	$ 15,200
Term Loan | Minimum
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Annual variable interest rate	9.00%

XML

Net Sales - Schedule of Disaggregation of Company's Net Sales by Major Source (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Disaggregation of Revenue [Line Items]
Total net sales	$ 94,213	$ 103,227
Retail Stores [Member]
Disaggregation of Revenue [Line Items]
Total net sales	56,464	62,987
Leased Departments [Member]
Disaggregation of Revenue [Line Items]
Total net sales	9,348	9,989
Total Retail Locations [Member]
Disaggregation of Revenue [Line Items]
Total net sales	65,812	72,976
E-commerce [Member]
Disaggregation of Revenue [Line Items]
Total net sales	22,672	25,482
Marketing Partnerships [Member]
Disaggregation of Revenue [Line Items]
Total net sales	4,580	3,935
Wholesale and Franchisee [Member]
Disaggregation of Revenue [Line Items]
Total net sales	$ 1,150	$ 834

XML

Other Charges - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Other Charges Related To Management And Organizational Changes And Proxy Solicitation [Abstract]
Charges related to management and organizational changes	$ 662	$ 264
Charges related to proxy solicitation		$ 886

XML

Other Charges - Summary of Charges Incurred in Management and Organizational Changes and Proxy Solicitation (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Other Charges Related To Management And Organizational Changes And Proxy Solicitation [Abstract]
Management and organizational changes	$ 662	$ 264
Proxy solicitation		886
Total other charges	$ 662	$ 1,150

XML

Government Incentives - Additional Information (Details) $ in Thousands	1 Months Ended	3 Months Ended
	Dec. 31, 2018 USD ($)	May 04, 2019 USD ($) Job	May 05, 2018 USD ($)	Feb. 02, 2019 USD ($)
Government Incentive Assistance Program [Line Items]
Deferred tax assets		$ 3,314		$ 2,671
Grow New Jersey Assistance Program (Grow NJ)
Government Incentive Assistance Program [Line Items]
Income tax credits granted from state incentive package		$ 40,000
Transferrable income tax credit period		10 years
Government incentive assistance program award period		10 years
Project development, eligible amount per new full time job		$ 7
Government incentive assistance program annual award limit		$ 4,000
Award compliance period		5 years
Award Compliance Description		After the end of the ten-year Grow NJ award earnings period there is a five-year compliance period during which the Company must maintain the average of its annual eligible jobs certified during the preceding ten years or a pro-rata amount up to one-tenth of the previously awarded income tax credits would be subject to recapture and repayment to the State of New Jersey annually during the five-year compliance period.
Agreement to sell annual income tax credits awarded, Description		up to 100%
Deferred tax assets		$ 3,314		$ 2,671
Cash proceeds net of costs from government incentive assistance program	$ 2,829
Cost reduction related to award		$ 617	$ 710
Grow New Jersey Assistance Program (Grow NJ) | Minimum
Government Incentive Assistance Program [Line Items]
Government incentive assistance program number of eligible jobs | Job		100

XML

Equity Award Plans - Additional Information (Details) - shares	3 Months Ended
	May 04, 2019	May 05, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of stock options granted with exercise price less than fair market value on grant date	0	0
Non-employee director
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Restricted stock, shares granted	4,000
2005 Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options to be issued	3,550,000
Common stock shares issued, restricted stock units or deferred stock units	2,250,000
Common stock available for grant	834,231
Target cumulative performance-based restricted stock units available for future declaration	113,326
Maximum cumulative restricted stock units available for future declaration	226,652
2005 Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	4 years
Share-based payment award, expiration period	10 years
2005 Plan | Restricted Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Awards that may be issued	177,500
2005 Plan | Performance-Based Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Performance period	3 years
2005 Plan | Maximum | Restricted Stock and Time-Based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period	4 years
2005 Plan | Minimum | Restricted Stock and Time-Based RSU
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, expiration period	1 year
Non-executive chairman
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment award, vesting period	1 year
Restricted stock, shares granted	6,000

XML

Equity Award Plans - Stock Option Activity for All Plans (Details) shares in Thousands	3 Months Ended
	May 04, 2019 $ / shares shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Outstanding Stock Options, Beginning balance | shares	439
Outstanding Stock Options, Granted | shares	45
Outstanding Stock Options, Forfeited | shares	(41)
Outstanding Stock Options, Ending balance | shares	443
Outstanding Stock Options, Exercisable | shares	161
Weighted Average Exercise Price, Beginning balance | $ / shares	$ 6.06
Weighted Average Exercise Price, Granted | $ / shares	2.33
Weighted Average Exercise Price, Forfeited | $ / shares	4.17
Weighted Average Exercise Price, Ending balance | $ / shares	5.85
Weighted Average Exercise Price, Exercisable | $ / shares	$ 9.75
Weighted Average Remaining Life, Outstanding	8 years 3 months 18 days
Weighted Average Remaining Life, Exercisable	6 years 8 months 12 days

XML

Equity Award Plans - Summarizes Information about Stock Options Outstanding (Details) shares in Thousands	3 Months Ended
	May 04, 2019 $ / shares shares
2.33 to 5.00
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	$ 2.33
Range of Exercise Prices, upper range	$ 5.00
Stock Options Outstanding, Number Outstanding | shares	237
Stock Options Outstanding, Weighted Average Remaining Life	9 years 2 months 12 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 2.63
Stock Options Exercisable, Number Exercisable | shares	43
Stock Options Exercisable, Weighted Average Exercise Price	$ 2.65
5.01 to 10.00
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	5.01
Range of Exercise Prices, upper range	$ 10.00
Stock Options Outstanding, Number Outstanding | shares	134
Stock Options Outstanding, Weighted Average Remaining Life	8 years 3 months 18 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 6.32
Stock Options Exercisable, Number Exercisable | shares	48
Stock Options Exercisable, Weighted Average Exercise Price	$ 7.49
10.01 to 31.38
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	10.01
Range of Exercise Prices, upper range	$ 31.38
Stock Options Outstanding, Number Outstanding | shares	72
Stock Options Outstanding, Weighted Average Remaining Life	5 years 2 months 12 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 15.53
Stock Options Exercisable, Number Exercisable | shares	70
Stock Options Exercisable, Weighted Average Exercise Price	$ 15.69
2.33 to 31.38
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, lower range	2.33
Range of Exercise Prices, upper range	$ 31.38
Stock Options Outstanding, Number Outstanding | shares	443
Stock Options Outstanding, Weighted Average Remaining Life	8 years 3 months 18 days
Stock Options Outstanding, Weighted Average Exercise Price	$ 5.85
Stock Options Exercisable, Number Exercisable | shares	161
Stock Options Exercisable, Weighted Average Exercise Price	$ 9.75

XML

Equity Award Plans - Restricted Stock Activity (Details) shares in Thousands	3 Months Ended
	May 04, 2019 $ / shares shares
Restricted stock activity for the 2005 Plan
Outstanding Restricted Shares, Unvested, beginning balance | shares	606
Outstanding Restricted Shares, Granted | shares	75
Outstanding Restricted Shares, Vested | shares	(64)
Outstanding Restricted Shares, Forfeited | shares	(100)
Outstanding Restricted Shares, Unvested, ending balance | shares	517
Weighted Average Grant Date Fair Value, Unvested, beginning balance | $ / shares	$ 3.34
Weighted Average Grant Date Fair Value, Granted | $ / shares	2.45
Weighted Average Grant Date Fair Value, Vested | $ / shares	2.72
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	2.68
Weighted Average Grant Date Fair Value, Unvested, ending balance | $ / shares	$ 3.26

XML

Recent Accounting Pronouncements - Additional Information (Details) - USD ($) $ in Thousands	May 04, 2019	Feb. 03, 2019
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Operating lease, right-of-use asset	$ 128,065
Operating lease, liability	$ 151,963
ASU 2016-02
New Accounting Pronouncements Or Change In Accounting Principle [Line Items]
Operating lease, right-of-use asset		$ 135,000
Operating lease, liability		159,000
Adjustment to accumulated deficit from impairment of certain operating lease ROU assets		$ 2,600

XML

Segment and Enterprise Wide Disclosures - Additional Information (Details)	3 Months Ended
	May 04, 2019 Segment Customer
Disclosure Segment And Enterprise Wide Disclosures Additional Information Detail [Abstract]
Number of operating segment | Segment	1
Number of customer who represented more than 10% of net sales | Customer	0

XML

Segment and Enterprise Wide Disclosures - Operations by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018	Feb. 02, 2019
Net Sales
Net sales	$ 94,213	$ 103,227
United States
Net Sales
Net sales	90,646	98,250
Long-Lived Assets
Long-Lived Assets	49,995		$ 51,068
Foreign
Net Sales
Net sales	3,567	$ 4,977
Long-Lived Assets
Long-Lived Assets	$ 1,078		$ 1,228

XML

Interest Expense, Net - Interest Expense, Net (Details) - USD ($) $ in Thousands	3 Months Ended
	May 04, 2019	May 05, 2018
Interest expense, net
Interest expense	$ 1,416	$ 1,158
Interest income	(1)	(1)
Interest expense, net	$ 1,415	$ 1,157